— Know what they know.
Not Investment Advice

VNDA NASDAQ

Vanda Pharmaceuticals Inc.
1W: -0.2% 1M: -20.5% 3M: -22.8% YTD: -51.5% 1Y: -28.7% 3Y: -5.7% 5Y: -77.5%
$4.00
+0.01 (+0.25%)
 
Weekly Expected Move ±5.0%
$4 $4 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 31 · $241.9M mcap · 57M float · 1.65% daily turnover · Short 52% of daily vol
Credit Risk of going bust: higher than 65% of companies Debt: 8.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99%), Vanda Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $22.8M against a stock market value of $241.9M.
Distance to default 3.81 (Merton model): prices to 2026-10-28, balance sheet 2026-06-30, debt counted $11.4M (short-term plus half of long-term), stock volatility 78.5%; Altman Z'' -4.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
#349 of 1062
Biotechnology
Healthcare · Micro Cap · 778 peers
Market Share
0.0%
Top 4 Concentration: 22.6%

Technical Signal Map

167 Bullish
48 Neutral
564 Bearish
VNDA $240M
Vanda Pharmaceuticals Inc.
BEARISH -66
SEPN $1.9B
Septerna Inc
BULLISH +100
KLRA $1.7B
Kailera Therapeutics, Inc.
BULLISH +100
COAG $1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH +100
REPL $1.1B
Replimune Group, Inc.
BULLISH +100
RIGL $900M
Rigel Pharmaceuticals, Inc.
BULLISH +100
SOLTF $770M
Nxera Pharma Co., Ltd.
BULLISH +100
CRMD $610M
CorMedix Inc.
BULLISH +100
DMAC $470M
DiaMedica Therapeutics Inc.
BULLISH +100
SGMT $310M
Sagimet Biosciences Inc.
BULLISH +100
DTIL $180M
Precision BioSciences, Inc.
BULLISH +100
MXCT $140M
MaxCyte, Inc.
BULLISH +100
PYPD $110M
PolyPid Ltd.
BULLISH +100
ANIX $100M
Anixa Biosciences, Inc.
BULLISH +100
NNVC $40M
NanoViricides, Inc.
BULLISH +100
VIR $1.8B
Vir Biotechnology, Inc.
BULLISH +91
SGP $950M
SpyGlass Pharma, Inc. Common Stock
BULLISH +91
VSTM $910M
Verastem, Inc.
BULLISH +91
ATNM $50M
Actinium Pharmaceuticals, Inc.
BULLISH +91
GRDX $40M
GridAI Technologies Corp.
BULLISH +91
MAZE $1.7B
Maze Therapeutics, Inc.
BULLISH +87
PRME $670M
Prime Medicine, Inc.
BULLISH +87
XFOR $320M
X4 Pharmaceuticals, Inc.
BULLISH +87
LYEL $230M
Lyell Immunopharma, Inc.
BULLISH +87
ZIVO $20M
ZIVO Bioscience, Inc.
BULLISH +87
PVLA $1.8B
Palvella Therapeutics, Inc.
BULLISH +84
RARE $1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH +84
OABIW $1.1B
OmniAb, Inc.
BULLISH +84
EDIT $370M
Editas Medicine, Inc.
BULLISH +84
INDP $360M
Indaptus Therapeutics, Inc.
BULLISH +84
KRRO $180M
Korro Bio, Inc.
BULLISH +84
PCSA $10M
Processa Pharmaceuticals, Inc.
BULLISH +84
IRLA $30M
IRulya Therapeutics Inc.
BULLISH +82
GENB $1.6B
Generate Biomedicines, Inc.
BULLISH +80
RXRX $2.0B
Recursion Pharmaceuticals, Inc.
BULLISH +78
CING $70M
Cingulate Inc.
BULLISH +78
ESLA $40M
Estrella Immunopharma, Inc.
BULLISH +78
ABSI $1.6B
Absci Corporation
BULLISH +75
TRAX $1.6B
First Tracks Biotherapeutics Inc
BULLISH +75
NTLA $1.6B
Intellia Therapeutics, Inc.
BULLISH +75
LBRX $1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH +75
ENTX $510M
Entera Bio Ltd.
BULLISH +75
KROS $220M
Keros Therapeutics, Inc.
BULLISH +75
HURA $140M
TuHURA Biosciences, Inc.
BULLISH +75
NRXS $90M
NeurAxis, Inc.
BULLISH +75
HOWL $50M
Werewolf Therapeutics, Inc.
BULLISH +75
PRLD $210M
Prelude Therapeutics Incorporated
BULLISH +73
NAUT $410M
Nautilus Biotechnolgy, Inc.
BULLISH +69
PRTA $420M
Prothena Corporation plc
BULLISH +68
GLSI $240M
Greenwich LifeSciences, Inc.
BULLISH +68
SRPT $1.9B
Sarepta Therapeutics, Inc.
BULLISH +66
XNCR $1.9B
Xencor, Inc.
BULLISH +66
XERS $1.9B
Xeris Biopharma Holdings, Inc.
BULLISH +66
SPTX $1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH +66
SLN $930M
Silence Therapeutics plc
BULLISH +66
ADCT $180M
ADC Therapeutics S.A.
BULLISH +66
ICCC $90M
ImmuCell Corporation
BULLISH +66
ADIL $10M
Adial Pharmaceuticals, Inc.
BULLISH +66
MBRX $10M
Moleculin Biotech, Inc.
BULLISH +66
ABPO —
Abpro Holdings, Inc.
BULLISH +66
PDSB $60M
PDS Biotechnology Corporation
BULLISH +65
AGTX —
Agentix Corp.
BULLISH +65
NBTX $1.5B
Nanobiotix S.A.
BULLISH +62
MLTX $1.0B
MoonLake Immunotherapeutics
BULLISH +62
PLUR $10M
Pluri Inc.
BULLISH +62
BOLT $10M
Bolt Biotherapeutics, Inc.
BULLISH +62
BDRX —
Biodexa Pharmaceuticals Plc
BULLISH +62
CBDG —
THC Farmaceuticals, Inc.
BULLISH +60
KNBIF —
Kane Biotech Inc.
BULLISH +60
STOK $1.6B
Stoke Therapeutics, Inc.
BULLISH +59
PHAR $710M
Pharming Group N.V.
BULLISH +59
CCCC $380M
C4 Therapeutics, Inc.
BULLISH +59
NGNE $370M
Neurogene Inc.
BULLISH +59
FENC $350M
Fennec Pharmaceuticals Inc.
BULLISH +59
ALEC $200M
Alector, Inc.
BULLISH +59
OKYO $70M
OKYO Pharma Limited
BULLISH +59
PBYI $570M
Puma Biotechnology, Inc.
BULLISH +58
AZTR —
Azitra, Inc.
BULLISH +58
BCYC $250M
Bicycle Therapeutics plc
BULLISH +52
LCTX $250M
Lineage Cell Therapeutics, Inc.
BULLISH +52
IMCR $1.6B
Immunocore Holdings plc
BULLISH +50
JANX $1.0B
Janux Therapeutics, Inc.
BULLISH +50
ACOG $130M
Alpha Cognition Inc
BULLISH +50
SCNLF $170M
Scancell Holdings plc
BULLISH +49
PULM $10M
Pulmatrix, Inc.
BULLISH +47
TCRT $10M
Alaunos Therapeutics, Inc.
BULLISH +44
CLGN —
CollPlant Biotechnologies Ltd.
BULLISH +44
ZBIO $1.8B
Zenas BioPharma, Inc.
BULLISH +43
VOR $990M
Vor Biopharma Inc.
BULLISH +43
DRUG $520M
Bright Minds Biosciences Inc.
BULLISH +43
ELDN $190M
Eledon Pharmaceuticals, Inc.
BULLISH +43
ABOS $140M
Acumen Pharmaceuticals, Inc.
BULLISH +43
PMN $70M
ProMIS Neurosciences, Inc.
BULLISH +43
HEPA —
Hepion Pharmaceuticals, Inc.
BULLISH +43
ACUT —
Accustem Sciences Inc.
BULLISH +43
NXTC $20M
NextCure, Inc.
BULLISH +42
KPTI $10M
Karyopharm Therapeutics Inc.
BULLISH +42
HALB —
Halberd Corporation
BULLISH +42
BRVE $1.5B
Braveheart Bio, Inc.
BULLISH +40
DMRA $1.3B
Damora Therapeutics, Inc.
BULLISH +40
PTCHF $390M
PureTech Health plc
BULLISH +40
IPIX —
Innovation Pharmaceuticals Inc.
BULLISH +38
TYRA $1.2B
Tyra Biosciences, Inc.
BULLISH +36
ARVN $470M
Arvinas, Inc.
BULLISH +36
DBVT $230M
DBV Technologies S.A.
BULLISH +35
TIL $40M
Instil Bio, Inc.
BULLISH +35
MDNAF $20M
Medicenna Therapeutics Corp.
BULLISH +35
OBX $10M
Obsidian Therapeutics Inc.
BULLISH +35
CALC —
CalciMedica, Inc.
BULLISH +35
KURA $850M
Kura Oncology, Inc.
BULLISH +34
RZLT $370M
Rezolute, Inc.
BULLISH +34
OBIO $340M
Orchestra BioMed Holdings, Inc.
BULLISH +34
PEPG $170M
PepGen Inc.
BULLISH +33
DNA $670M
Ginkgo Bioworks Holdings, Inc.
BULLISH +32
QURE $1.6B
uniQure N.V.
LEAN BULL +29
BCRX $1.9B
BioCryst Pharmaceuticals, Inc.
LEAN BULL +27
CMPS $1.6B
COMPASS Pathways plc
LEAN BULL +27
OVID $420M
Ovid Therapeutics Inc.
LEAN BULL +27
SABS $260M
SAB Biotherapeutics, Inc.
LEAN BULL +27
CLNN $60M
Clene Inc.
LEAN BULL +27
BIVI $10M
BioVie Inc.
LEAN BULL +27
INFIQ —
Infinity Pharmaceuticals, Inc.
LEAN BULL +27
ARDS —
Aridis Pharmaceuticals, Inc.
LEAN BULL +27
BSSP —
Baseline Productions, Inc.
LEAN BULL +27
VCRE $260M
Vicore Pharma Holding AB
LEAN BULL +26
INKT $50M
MiNK Therapeutics, Inc.
LEAN BULL +26
CKDXF $10M
Ceryvyn Therapeutics Ltd
LEAN BULL +26
CYYNF —
Cynata Therapeutics Limited
LEAN BULL +26
VAXX —
Vaxxinity, Inc.
LEAN BULL +26
ANAB $1.5B
AnaptysBio, Inc.
LEAN BULL +22
IMRX $240M
Immuneering Corporation
LEAN BULL +22
INVA $1.5B
Innoviva, Inc.
LEAN BULL +18
YDES $350M
YD Bio Limited Ordinary Shares
LEAN BULL +18
ZURA $320M
Zura Bio Limited
LEAN BULL +18
FATE $250M
Fate Therapeutics, Inc.
LEAN BULL +18
MDWD $150M
MediWound Ltd.
LEAN BULL +18
RNXT $60M
RenovoRx, Inc.
LEAN BULL +18
VSBC $10M
VitaSpring Biomedical Co. Ltd.
LEAN BULL +18
LOBEF $10M
Lobe Sciences Ltd.
LEAN BULL +18
PXMD —
PaxMedica, Inc. Common Stock
LEAN BULL +18
SCPX —
Scorpius Holdings, Inc.
LEAN BULL +18
REVB —
Revelation Biosciences, Inc.
LEAN BULL +18
IUGNF $30M
Imugene Limited
LEAN BULL +17
CURX $10M
Curanex Pharmaceuticals Inc Common Stock
LEAN BULL +17
ACRS $550M
Aclaris Therapeutics, Inc.
LEAN BULL +16
RNA $140M
Atrium Therapeutics, Inc.
LEAN BULL +16
TXTM $90M
ProText Mobility, Inc.
LEAN BULL +16
CLCS $40M
Cell Source, Inc.
LEAN BULL +16
SRZN $190M
Surrozen, Inc.
LEAN BULL +15
ANTX $130M
AN2 Therapeutics, Inc.
LEAN BULL +15
PBLA —
Panbela Therapeutics, Inc.
LEAN BULL +15
NMAD $50M
NOMAD Power Solutions, Inc.
LEAN BULL +14
WVE $630M
Wave Life Sciences Ltd.
LEAN BULL +13
SPRB $130M
Spruce Biosciences, Inc.
LEAN BULL +13
ZEOX $10M
Zeo ScientifiX, Inc.
LEAN BULL +13
ENSC $10M
Ensysce Biosciences, Inc.
LEAN BULL +12
NWBO $260M
Northwest Biotherapeutics, Inc.
LEAN BULL +11
CHRS $160M
Coherus Oncology, Inc.
LEAN BULL +11
OKUR $100M
OnKure Therapeutics, Inc.
LEAN BULL +11
EHOS —
Ehouse Global, Inc.
LEAN BULL +11
BETRF $110M
BetterLife Pharma Inc.
LEAN BULL +10
LITS $40M
Lite Strategy, Inc.
LEAN BULL +10
LEXX $10M
Lexaria Bioscience Corp.
LEAN BULL +10
ENVB $10M
Enveric Biosciences, Inc.
LEAN BULL +10
NMTRQ —
9 Meters Biopharma, Inc.
LEAN BULL +10
CMRA —
Comera Life Sciences Holdings, Inc.
LEAN BULL +10
DNAG —
DNAPrint Genomics, Inc.
LEAN BULL +10
ONCSQ —
OncoSec Medical Incorporated
LEAN BULL +10
ABVC $30M
ABVC BioPharma, Inc.
NEUTRAL +9
IFRX $230M
InflaRx N.V.
NEUTRAL +8
LONA $20M
LeonaBio, Inc.
NEUTRAL +8
ADXN —
Addex Therapeutics Ltd
NEUTRAL +7
CYDY $380M
CytoDyn Inc.
NEUTRAL +5
CGEM $880M
Cullinan Therapeutics, Inc.
NEUTRAL +4
QTTB $260M
Q32 Bio Inc.
NEUTRAL +4
EVMN $190M
Evommune, Inc.
NEUTRAL +4
GBIM —
GlobeImmune, Inc.
NEUTRAL +4
OCEA —
Ocean Biomedical, Inc.
NEUTRAL +4
BPTH —
Bio-Path Holdings, Inc.
NEUTRAL +3
CARM —
Carisma Therapeutics, Inc.
NEUTRAL +3
FULC $280M
Fulcrum Therapeutics, Inc.
NEUTRAL +2
FHTX $120M
Foghorn Therapeutics Inc.
NEUTRAL +2
RNTX $50M
Rein Therapeutics Inc.
NEUTRAL +2
GDTC $10M
CytoMed Therapeutics Limited
NEUTRAL +2
ONCO —
Onconetix, Inc.
NEUTRAL +2
HESG —
Health Sciences Group, Inc.
NEUTRAL +2
NTRR —
Neutra Corp.
NEUTRAL +2
STTK $550M
Shattuck Labs, Inc.
NEUTRAL +1
ARCT $280M
Arcturus Therapeutics Holdings Inc.
NEUTRAL +1
CTXR $10M
Citius Pharmaceuticals, Inc.
NEUTRAL +1
NKGN —
NKGen Biotech, Inc.
NEUTRAL +1
YDESW —
YD Bio Limited Warrants
NEUTRAL +1
CFRXQ —
ContraFect Corp.
NEUTRAL +1
RBSH —
Rebus Holdings, Inc.
NEUTRAL +1
LYCA $1.6B
Lycia Therapeutics Inc.
N/A 0
CTY $200M
City Therapeutics Inc.
N/A 0
IAM $130M
Iambic Therapeutics Inc.
N/A 0
ACHFF $40M
Arch Biopartners Inc.
NEUTRAL 0
ATOS $30M
Atossa Therapeutics, Inc.
NEUTRAL 0
ODTX $940M
Odyssey Therapeutics, Inc.
NEUTRAL -2
JBIO $930M
Jade Biosciences, Inc.
NEUTRAL -2
SVRA $870M
Savara Inc.
NEUTRAL -5
SNGX $10M
Soligenix, Inc.
NEUTRAL -5
KLDO —
Kaleido Biosciences, Inc.
NEUTRAL -5
ALMS $880M
Alumis Inc.
NEUTRAL -6
YARW $180M
Yarrow Bioscience Inc
NEUTRAL -6
EQ $80M
Equillium, Inc.
NEUTRAL -6
ELTX $40M
Elicio Therapeutics, Inc.
NEUTRAL -6
NYMXF $10M
Nymox Pharmaceutical Corporation
NEUTRAL -6
RVLPQ —
RVL Pharmaceuticals plc
NEUTRAL -7
WHWK $180M
Whitehawk Therapeutics Inc
NEUTRAL -9
PYXS $110M
Pyxis Oncology, Inc.
NEUTRAL -9
ELUT $40M
Elutia Inc
NEUTRAL -9
EVAX $20M
Evaxion Biotech A/S
NEUTRAL -9
LADX —
LadRx Corporation
NEUTRAL -9
MRPI —
Mera Pharmaceuticals, Inc.
NEUTRAL -9
MBXBF $30M
Microbix Biosystems Inc.
LEAN BEAR -10
XBIO —
Xenetic Biosciences, Inc.
LEAN BEAR -10
MLLCF $150M
Molecular Partners AG
LEAN BEAR -12
POLBF $70M
Poolbeg Pharma PLC
LEAN BEAR -12
CLYYF $10M
Celyad Oncology S.A.
LEAN BEAR -12
QPTFF $10M
Quest PharmaTech Inc.
LEAN BEAR -12
CAMP $210M
CAMP4 Therapeutics Corporation
LEAN BEAR -14
ENTA $340M
Enanta Pharmaceuticals, Inc.
LEAN BEAR -15
AGEN $290M
Agenus Inc.
LEAN BEAR -15
BIOA $190M
BioAge Labs Inc.
LEAN BEAR -15
ALXO $160M
ALX Oncology Holdings Inc.
LEAN BEAR -15
AURX $60M
Nuo Therapeutics, Inc.
LEAN BEAR -15
JSPR $20M
Jasper Therapeutics, Inc.
LEAN BEAR -15
CNBX —
CNBX Pharmaceuticals Inc.
LEAN BEAR -15
GYRE $620M
Gyre Therapeutics, Inc.
LEAN BEAR -16
NTRB $70M
Nutriband Inc.
LEAN BEAR -16
BOLD $50M
Boundless Bio, Inc.
LEAN BEAR -16
AEON $10M
AEON Biopharma, Inc.
LEAN BEAR -16
SRBCF —
Sirona Biochem Corp.
LEAN BEAR -16
SNNAQ —
Sienna Biopharmaceuticals, Inc.
LEAN BEAR -16
PPCB —
Propanc Biopharma, Inc.
LEAN BEAR -16
IMVIF —
IMV Inc.
LEAN BEAR -16
MCET —
MultiCell Technologies, Inc.
LEAN BEAR -16
TRVI $1.8B
Trevi Therapeutics, Inc.
LEAN BEAR -17
AURA $650M
Aura Biosciences, Inc.
LEAN BEAR -17
TTRX $310M
Turn Therapeutics Inc.
LEAN BEAR -17
MMIRF $30M
MedMira Inc.
LEAN BEAR -17
SLDB $630M
Solid Biosciences Inc.
LEAN BEAR -18
XTLB —
XTL Biopharmaceuticals Ltd.
LEAN BEAR -18
LYRA —
Lyra Therapeutics, Inc.
LEAN BEAR -18
PARD —
Poniard Pharmaceuticals, Inc.
LEAN BEAR -18
STAB —
Statera Biopharma, Inc.
LEAN BEAR -18
AOBI —
American Oriental Bioengineering, Inc.
LEAN BEAR -20
HSTC $210M
HST Global, Inc.
LEAN BEAR -21
TSHA $1.3B
Taysha Gene Therapies, Inc.
LEAN BEAR -22
CLLS $100M
Cellectis S.A.
LEAN BEAR -22
IMUX $100M
Immunic, Inc.
LEAN BEAR -22
GRCE $30M
Grace Therapeutics, Inc.
LEAN BEAR -22
PBIGF $10M
Paradigm Biopharmaceuticals Limited
LEAN BEAR -22
PREDQ —
Predictive Discovery Limited
LEAN BEAR -22
MNKD $1.0B
MannKind Corporation
LEAN BEAR -23
RCKT $250M
Rocket Pharmaceuticals, Inc.
LEAN BEAR -23
CSBR $70M
Champions Oncology, Inc.
LEAN BEAR -23
GOSS $60M
Gossamer Bio, Inc.
LEAN BEAR -23
KARD $1.1B
Kardigan, Inc.
LEAN BEAR -24
FDMT $600M
4D Molecular Therapeutics, Inc.
LEAN BEAR -24
RNAC $190M
Cartesian Therapeutics, Inc.
LEAN BEAR -24
CGEN $180M
Compugen Ltd.
LEAN BEAR -24
TRDA $170M
Entrada Therapeutics, Inc.
LEAN BEAR -24
BDTX $110M
Black Diamond Therapeutics, Inc.
LEAN BEAR -24
NTHI $90M
Neonc Technologies Holdings, Inc.
LEAN BEAR -24
SGMOQ $50M
Sangamo Therapeutics, Inc.
LEAN BEAR -24
PZRXQ —
PhaseRx, Inc.
LEAN BEAR -24
RNAZ —
TransCode Therapeutics, Inc.
LEAN BEAR -24
REPCF —
RepliCel Life Sciences Inc.
LEAN BEAR -24
NNBP —
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR -24
NNLX —
NanoLogix, Inc.
LEAN BEAR -24
CLAZF —
Claritas Pharmaceuticals, Inc.
LEAN BEAR -24
GWIN $360M
Glorywin Entertainment Group, Inc.
LEAN BEAR -25
FGHQF $360M
Frontage Holdings Corporation
LEAN BEAR -25
KNTPF $120M
Kintor Pharmaceutical Limited
LEAN BEAR -25
HUMA $120M
Humacyte, Inc.
LEAN BEAR -25
LVCLF $20M
Algorae Pharmaceuticals Limited
LEAN BEAR -25
BCLI $10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR -25
ENGNW $10M
enGene Holdings Inc. Warrants
LEAN BEAR -25
FORU —
ForU Holdings, Inc.
LEAN BEAR -25
CHNXF —
ChitogenX Inc.
LEAN BEAR -25
HLSQ —
Tessera Defense and Homeland Security Inc
LEAN BEAR -25
JUNS —
Jupiter Neurosciences, Inc.
LEAN BEAR -25
CMND —
Clearmind Medicine Inc.
LEAN BEAR -25
VINC —
Vincerx Pharma, Inc.
LEAN BEAR -25
NURPF $1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR -26
CUBT —
Curative Biotechnology, Inc.
LEAN BEAR -26
NRXP $110M
NRx Pharmaceuticals, Inc.
LEAN BEAR -27
CNTN $150M
Canton Strategic Holdings Inc
LEAN BEAR -28
CNSP $10M
CNS Pharmaceuticals, Inc.
LEAN BEAR -28
ADRX $1.9B
ADARx Pharmaceuticals, Inc.
LEAN BEAR -29
ANNX $610M
Annexon, Inc.
BEARISH -30
IMA $50M
ImageneBio Inc
BEARISH -30
GLUE $920M
Monte Rosa Therapeutics, Inc.
BEARISH -31
SANA $700M
Sana Biotechnology, Inc.
BEARISH -31
OCS $490M
Oculis Holding AG
BEARISH -31
RLMD $350M
Relmada Therapeutics, Inc.
BEARISH -31
IBO $30M
Impact BioMedical Inc.
BEARISH -31
LTRN $10M
Lantern Pharma Inc.
BEARISH -31
KZIA $10M
Kazia Therapeutics Ltd ADR
BEARISH -31
ADAPY $10M
Adaptimmune Therapeutics plc
BEARISH -31
ALLR $10M
Allarity Therapeutics, Inc.
BEARISH -31
PBMWW —
Psyence Biomedical Ltd. Warrant
BEARISH -31
LIPO —
Lipella Pharmaceuticals Inc.
BEARISH -31
TRVN —
Trevena, Inc.
BEARISH -31
PKTX —
ProtoKinetix, Incorporated
BEARISH -31
IMMB —
Immunotech Laboratories, Inc.
BEARISH -31
ALLO $430M
Allogene Therapeutics, Inc.
BEARISH -32
PMVP $70M
PMV Pharmaceuticals, Inc.
BEARISH -32
SPRO $60M
Spero Therapeutics, Inc.
BEARISH -32
SNANF $20M
Sona Nanotech Inc.
BEARISH -32
SNTI $10M
Senti Biosciences, Inc.
BEARISH -32
IMUC $10M
EOM Pharmaceuticals Holdings, Inc.
BEARISH -32
HTDS —
Hard to Treat Diseases Inc.
BEARISH -32
AAPG $1.4B
Ascentage Pharma Group International
BEARISH -33
SNBIF $1.3B
SanBio Company Limited
BEARISH -33
SLGL $230M
Sol-Gel Technologies Ltd.
BEARISH -33
APLMW $170M
Apollomics, Inc.
BEARISH -33
MRKR $20M
Marker Therapeutics, Inc.
BEARISH -33
VRCI —
Verde Science, Inc.
BEARISH -33
NTII —
Neurobiological Technologies, Inc.
BEARISH -33
IBOGF —
Universal Ibogaine Inc.
BEARISH -33
RGIN —
Regenicin, Inc.
BEARISH -33
GLSHQ —
Gelesis Holdings, Inc.
BEARISH -33
HAVLF —
HAVN Life Sciences Inc.
BEARISH -33
TLOG —
TetraLogic Pharmaceuticals Corporation
BEARISH -33
PSYBF —
PsyBio Therapeutics Corp
BEARISH -33
MAJI —
Nextel Medical Corp.
BEARISH -33
GRI —
GRI Bio, Inc.
BEARISH -33
MRZM —
Marizyme, Inc.
BEARISH -33
BPMUF $960M
Basilea Pharmaceutica AG
BEARISH -34
AKBA $160M
Akebia Therapeutics, Inc.
BEARISH -34
ATRA $90M
Atara Biotherapeutics, Inc.
BEARISH -34
SYGGF —
Synairgen plc
BEARISH -34
BTAX —
Biostax Corp.
BEARISH -34
CLYM $590M
Climb Bio, Inc.
BEARISH -35
MNPR $470M
Monopar Therapeutics Inc.
BEARISH -35
ATGGF $140M
Actinogen Medical Limited
BEARISH -35
BVAXF —
BioVaxys Technology Corp.
BEARISH -35
SQZB —
SQZ Biotechnologies Company
BEARISH -35
VOGX $260M
Vogenx Inc.
BEARISH -36
MEOBF $2.0B
Mesoblast Limited
BEARISH -37
MLYS $1.8B
Mineralys Therapeutics, Inc.
BEARISH -40
IMTX $1.1B
Immatics N.V.
BEARISH -40
AKTS $850M
Aktis Oncology, Inc.
BEARISH -40
ATTO $630M
Attovia Therapeutics, Inc.
BEARISH -40
OLMA $560M
Olema Pharmaceuticals, Inc.
BEARISH -40
BNTC $300M
Benitec Biopharma Inc.
BEARISH -40
TARA $140M
Protara Therapeutics, Inc.
BEARISH -40
OTLK $130M
Outlook Therapeutics, Inc.
BEARISH -40
AKTX $20M
Akari Therapeutics, Plc
BEARISH -40
NCNA $10M
NuCana plc
BEARISH -40
LIFS —
Life Stem Genetics Inc.
BEARISH -40
RLFTY —
MindMaze Therapeutics Holding S.A.
BEARISH -40
LGVN —
Longeveron Inc.
BEARISH -40
JAGX —
Jaguar Health, Inc.
BEARISH -40
DRMA —
Dermata Therapeutics, Inc.
BEARISH -40
ITMC —
Itoco Inc.
BEARISH -40
GBLX —
GB Sciences, Inc.
BEARISH -40
GNLX $90M
Genelux Corporation
BEARISH -41
ERNA —
Ernexa Therapeutics Inc.
BEARISH -41
AAGH —
America Great Health
BEARISH -41
MRES —
Institute of Biomedical Research Corp.
BEARISH -41
CSPHF $1.4B
CStone Pharmaceuticals
BEARISH -42
DRTSW $1.2B
Alpha Tau Medical Ltd.
BEARISH -42
XCUR $10M
Exicure, Inc.
BEARISH -42
PRVCF $10M
PreveCeutical Medical Inc.
BEARISH -42
LSTA $10M
Lisata Therapeutics, Inc.
BEARISH -42
ERNAW —
Ernexa Therapeutics Inc. Warrants
BEARISH -42
PROT —
Proteonomix, Inc.
BEARISH -42
NBIO —
Nascent Biotech, Inc.
BEARISH -42
RNUGF —
ReNeuron Group plc
BEARISH -42
PFND —
Pathfinder Cell Therapy, Inc.
BEARISH -42
CDXI —
Cardax, Inc.
BEARISH -42
ADYX —
Adynxx, Inc.
BEARISH -42
PANC —
Panacos Pharmaceuticals, Inc.
BEARISH -42
SYVC —
Synovics Pharmaceuticals, Inc.
BEARISH -42
GHRS $1.2B
GH Research PLC
BEARISH -43
DSGN $640M
Design Therapeutics, Inc.
BEARISH -43
TENX $50M
Tenax Therapeutics, Inc.
BEARISH -43
HNSBF $330M
Hansa Biopharma AB (publ)
BEARISH -44
VICP $10M
Vicapsys Life Sciences, Inc.
BEARISH -44
ANTH —
Anthera Pharmaceuticals, Inc.
BEARISH -44
PLYX $90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH -46
CASIF —
CASI Pharmaceuticals, Inc.
BEARISH -46
IDRSF $1.4B
Idorsia Ltd
BEARISH -47
VBIZF $400M
Viva Biotech Holdings
BEARISH -47
SYRS —
Syros Pharmaceuticals, Inc.
BEARISH -47
FPMI —
FluoroPharma Medical, Inc.
BEARISH -47
CASBF $1.4B
CanSino Biologics Inc.
BEARISH -48
CRVS $890M
Corvus Pharmaceuticals, Inc.
BEARISH -48
NKTR $1.1B
Nektar Therapeutics
BEARISH -49
RGNX $440M
REGENXBIO Inc.
BEARISH -49
BLSM $430M
BlossomHill Therapeutics, Inc.
BEARISH -49
TECX $390M
Tectonic Therapeutic, Inc.
BEARISH -49
IPSC $260M
Century Therapeutics, Inc.
BEARISH -49
NAGE $190M
Niagen Bioscience Inc
BEARISH -49
MAIA $70M
MAIA Biotechnology, Inc.
BEARISH -49
HMTXF $10M
Hemostemix Inc.
BEARISH -49
SCPS —
Scopus BioPharma Inc.
BEARISH -49
BITRF —
Biotron Limited
BEARISH -49
THER —
Theralink Technologies, Inc.
BEARISH -49
CVKD —
Cadrenal Therapeutics, Inc. Common Stock
BEARISH -49
MLECW —
Moolec Science S.A.
BEARISH -49
VIVS —
VivoSim Labs, Inc.
BEARISH -49
PPTDF $870M
PeptiDream Inc.
BEARISH -50
SPHRY $220M
Starpharma Holdings Limited
BEARISH -50
HRGN $30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH -50
LPCN $10M
Lipocine Inc.
BEARISH -50
BRAXF —
Braxia Scientific Corp.
BEARISH -50
SIGY —
Sigyn Therapeutics, Inc.
BEARISH -50
VRPX —
Virpax Pharmaceuticals, Inc.
BEARISH -50
VRAX —
Virax Biolabs Group Limited
BEARISH -50
ATXI —
Avenue Therapeutics, Inc.
BEARISH -50
SCNI —
Scinai Immunotherapeutics Ltd.
BEARISH -50
CALA —
Calithera Biosciences, Inc.
BEARISH -51
ANRO $860M
Alto Neuroscience, Inc.
BEARISH -52
ABUS $830M
Arbutus Biopharma Corp
BEARISH -52
HOPHF $20M
Hemogenyx Pharmaceuticals Plc
BEARISH -52
NUVB $1.6B
Nuvation Bio Inc.
BEARISH -53
AUTL $410M
Autolus Therapeutics plc
BEARISH -53
PLX $210M
Protalix BioTherapeutics, Inc.
BEARISH -53
RLYB $90M
Rallybio Corporation
BEARISH -53
ALZN $10M
Alzamend Neuro Inc
BEARISH -53
AFFY —
Affymax, Inc.
BEARISH -53
OCUL $1.4B
Ocular Therapeutix, Inc.
BEARISH -56
LRMR $240M
Larimar Therapeutics, Inc.
BEARISH -56
LXEO $230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH -56
MENS $130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH -56
ADAG $90M
Adagene Inc.
BEARISH -56
WINT —
Windtree Therapeutics, Inc.
BEARISH -56
SILO —
Silo Pharma, Inc.
BEARISH -56
OMER $1.2B
Omeros Corporation
BEARISH -58
AVBP $1.0B
ArriVent BioPharma, Inc.
BEARISH -58
EPRX $450M
Eupraxia Pharmaceuticals Inc.
BEARISH -58
CABA $250M
Cabaletta Bio, Inc.
BEARISH -58
ARMP $140M
Armata Pharmaceuticals, Inc.
BEARISH -58
VRXA $140M
Veraxa Biotech Holding AG
BEARISH -58
UNCY $110M
Unicycive Therapeutics, Inc.
BEARISH -58
INO $60M
Inovio Pharmaceuticals, Inc.
BEARISH -58
VERU $40M
Veru Inc.
BEARISH -58
ANVS $40M
Annovis Bio, Inc.
BEARISH -58
SEOVF $30M
Sernova Corp.
BEARISH -58
DVHGF $20M
Devonian Health Group, Inc.
BEARISH -58
DYAI $20M
Dyadic International, Inc.
BEARISH -58
BIORQ —
Biora Therapeutics, Inc.
BEARISH -58
ATRX —
Adhera Therapeutics Inc
BEARISH -58
SXTP —
60 Degrees Pharmaceuticals, Inc.
BEARISH -58
EVGN —
Evogene Ltd.
BEARISH -58
BLEG —
Branded Legacy, Inc.
BEARISH -58
CRIS —
Curis, Inc.
BEARISH -58
AMPE —
Ampio Pharmaceuticals, Inc.
BEARISH -58
ORIC $1.4B
ORIC Pharmaceuticals, Inc.
BEARISH -59
KPRX $10M
Kiora Pharmaceuticals, Inc.
BEARISH -59
BCTXZ —
BriaCell Therapeutics Corp. Warrant
BEARISH -59
RAPP $1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH -60
DRTS $1.2B
Alpha Tau Medical Ltd
BEARISH -60
MGTX $880M
MeiraGTx Holdings plc
BEARISH -60
ORMP $170M
Oramed Pharmaceuticals Inc.
BEARISH -60
BRIBF $90M
Brii Biosciences Limited
BEARISH -60
ELOX $40M
Eloxx Pharmaceuticals, Inc.
BEARISH -60
SYBX $10M
Synlogic, Inc.
BEARISH -60
FBIOP $130M
Fortress Biotech, Inc.
BEARISH -62
ORGS —
Orgenesis Inc.
BEARISH -62
AVLN $1.1B
Avalyn Pharma Inc. Common Stock
BEARISH -65
APMD $790M
Apnimed, Inc.
BEARISH -65
CBIO $480M
Crescent Biopharma, Inc.
BEARISH -65
KYTX $330M
Kyverna Therapeutics, Inc.
BEARISH -65
MIST $80M
Milestone Pharmaceuticals Inc.
BEARISH -65
RECEF $70M
Recce Pharmaceuticals Ltd
BEARISH -65
TELO $70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH -65
NMRA $70M
Neumora Therapeutics, Inc. Common Stock
BEARISH -65
CNTB $50M
Connect Biopharma Holdings Limited
BEARISH -65
CVM $30M
CEL-SCI Corporation
BEARISH -65
ARTL $10M
Artelo Biosciences, Inc.
BEARISH -65
FNAM —
Evolutionary Genomics, Inc.
BEARISH -65
SYBE —
SYBLEU Inc
BEARISH -65
RGRX —
RegeneRx Biopharmaceuticals, Inc.
BEARISH -65
BICTF —
Biocure Technology Inc.
BEARISH -65
GERN $720M
Geron Corporation
BEARISH -66
ZVRA $580M
Zevra Therapeutics, Inc.
BEARISH -66
PHAT $460M
Phathom Pharmaceuticals, Inc.
BEARISH -66
FTH $440M
Faeth Therapeutics, Inc.
BEARISH -66
CLVLF $250M
Clinuvel Pharmaceuticals Limited
BEARISH -66
UPB $150M
Upstream Bio, Inc.
BEARISH -66
CUE $140M
Cue Biopharma, Inc.
BEARISH -66
LENZ $100M
LENZ Therapeutics, Inc.
BEARISH -66
ACRV $70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH -66
NDTP $50M
NDT Pharmaceuticals Inc.
BEARISH -66
INNMF $30M
Amplia Therapeutics Limited
BEARISH -66
RVXCF $20M
Resverlogix Corp.
BEARISH -66
DTCFF $20M
Defence Therapeutics Inc.
BEARISH -66
OTLC $10M
Oncotelic Therapeutics, Inc.
BEARISH -66
ICU $10M
SeaStar Medical Holding Corporation
BEARISH -66
INTS $10M
Intensity Therapeutics, Inc.
BEARISH -66
PLRZ $10M
Polyrizon Ltd.
BEARISH -66
PHIO $10M
Phio Pharmaceuticals Corp.
BEARISH -66
CDT —
CDT Equity Inc.
BEARISH -66
APUS —
Apimeds Pharmaceuticals US, Inc
BEARISH -66
ADTX —
Aditxt, Inc.
BEARISH -66
AMBS —
Amarantus BioScience Holdings, Inc.
BEARISH -66
YECO —
EV Biologics, Inc.
BEARISH -66
BRTX —
BioRestorative Therapies, Inc.
BEARISH -66
AFMDQ —
Affimed N.V.
BEARISH -66
SPRC —
SciSparc Ltd.
BEARISH -66
MTNB —
Matinas BioPharma Holdings, Inc.
BEARISH -66
AGNPF —
Grey Matters Health Inc.
BEARISH -66
VBIO —
Valion Bio, Inc.
BEARISH -66
RGBPP —
Regen BioPharma, Inc.
BEARISH -66
NVAX $1.6B
Novavax, Inc.
BEARISH -69
PRQR $180M
ProQR Therapeutics N.V.
BEARISH -69
AMGXF $140M
AnGes, Inc.
BEARISH -69
BBIXF $50M
Bonus BioGroup Ltd.
BEARISH -69
INTI $10M
Inhibitor Therapeutics, Inc.
BEARISH -69
MYMX —
Mymetics Corporation
BEARISH -69
NWPHF $410M
Newron Pharmaceuticals S.p.A.
BEARISH -71
VRXAW —
Veraxa Biotech AG
BEARISH -71
SRNE —
Sorrento Therapeutics, Inc.
BEARISH -73
SNDX $1.2B
Syndax Pharmaceuticals, Inc.
BEARISH -74
CTMX $510M
CytomX Therapeutics, Inc.
BEARISH -74
ASMB $400M
Assembly Biosciences, Inc.
BEARISH -74
MPLT $340M
MapLight Therapeutics, Inc.
BEARISH -74
CTNM $270M
Contineum Therapeutics, Inc.
BEARISH -74
ABEO $250M
Abeona Therapeutics Inc.
BEARISH -74
CRBU $60M
Caribou Biosciences, Inc.
BEARISH -74
IBIO $50M
iBio, Inc.
BEARISH -74
CLRB $10M
Cellectar Biosciences, Inc.
BEARISH -74
AIM $10M
AIM ImmunoTech Inc.
BEARISH -74
BTAIQ —
BioXcel Therapeutics, Inc.
BEARISH -74
ASCLF $770M
Ascletis Pharma Inc.
BEARISH -75
ACHV $670M
Achieve Life Sciences, Inc.
BEARISH -75
NVCT $650M
Nuvectis Pharma, Inc.
BEARISH -75
IRD $290M
Opus Genetics, Inc.
BEARISH -75
PALI $230M
Palisade Bio, Inc.
BEARISH -75
GALT $210M
Galectin Therapeutics Inc.
BEARISH -75
MGNX $140M
MacroGenics, Inc.
BEARISH -75
SEER $110M
Seer, Inc.
BEARISH -75
COYA $90M
Coya Therapeutics, Inc.
BEARISH -75
MNOV $70M
MediciNova, Inc.
BEARISH -75
OSTX $60M
OS Therapies Incorporated
BEARISH -75
HRTX $60M
Heron Therapeutics, Inc.
BEARISH -75
XLO $50M
Xilio Therapeutics, Inc.
BEARISH -75
GANX $50M
Gain Therapeutics, Inc.
BEARISH -75
ALPS $50M
Alps Group Inc
BEARISH -75
MREO $40M
Mereo BioPharma Group plc
BEARISH -75
DWTX $40M
Dogwood Therapeutics, Inc.
BEARISH -75
PVCT $20M
Provectus Biopharmaceuticals, Inc.
BEARISH -75
COCP $20M
Cocrystal Pharma, Inc.
BEARISH -75
IMRN $10M
Immuron Limited
BEARISH -75
PHYOF $10M
IXICO plc
BEARISH -75
PASG $10M
Passage Bio, Inc.
BEARISH -75
GLWLF $10M
Glow Lifetech Corp.
BEARISH -75
EVLO —
Evelo Biosciences, Inc.
BEARISH -75
ISCO —
International Stem Cell Corporation
BEARISH -75
HMGN —
Hemagen Diagnostics, Inc.
BEARISH -75
RCAR —
RenovaCare, Inc.
BEARISH -75
ELAB —
PMGC Holdings Inc.
BEARISH -75
CHMMF —
Chimeric Therapeutics Limited
BEARISH -75
LIANY —
LianMedical
BEARISH -75
VCNX —
Vaccinex, Inc.
BEARISH -75
AXIM —
AXIM Biotechnologies, Inc.
BEARISH -75
LNAI —
Lunai Bioworks Inc.
BEARISH -75
IMMX $680M
Immix Biopharma, Inc.
BEARISH -78
LXRX $630M
Lexicon Pharmaceuticals, Inc.
BEARISH -78
CADL $610M
Candel Therapeutics, Inc.
BEARISH -78
MDXG $570M
MiMedx Group, Inc.
BEARISH -78
AVIR $320M
Atea Pharmaceuticals, Inc.
BEARISH -78
IKT $220M
Inhibikase Therapeutics, Inc.
BEARISH -78
INMB $40M
INmune Bio, Inc.
BEARISH -78
BMEA $40M
Biomea Fusion, Inc.
BEARISH -78
CELU $30M
Celularity Inc.
BEARISH -78
AVEFF $20M
Avecho Biotechnology Limited
BEARISH -78
SER $20M
Serina Therapeutics, Inc.
BEARISH -78
CMMB $10M
Chemomab Therapeutics Ltd.
BEARISH -78
CPMV —
Mosaic ImmunoEngineering Inc.
BEARISH -78
XRTX —
XORTX Therapeutics Inc.
BEARISH -78
OZYMF —
Strategic Partners A/S
BEARISH -78
GNLKQ —
GeneLink, Inc.
BEARISH -78
GLABF —
Gemina Laboratories Ltd.
BEARISH -78
PBM —
Psyence Biomedical Ltd.
BEARISH -78
HXBM —
Helix BioMedix, Inc.
BEARISH -78
KRSA $150M
Korsana Biosciences, Inc.
BEARISH -80
HBMHF $1.3B
HBM Holdings Limited
BEARISH -82
GPCR $1.2B
Structure Therapeutics Inc.
BEARISH -82
ARDX $770M
Ardelyx, Inc.
BEARISH -82
SLBT $640M
SL Science Holding Ltd
BEARISH -82
PROK $470M
ProKidney Corp.
BEARISH -82
ACIU $250M
AC Immune S.A.
BEARISH -82
BOVNF $220M
BioInvent International AB (publ)
BEARISH -82
BBOT $210M
BridgeBio Oncology Therapeutics Inc.
BEARISH -82
IVVD $180M
Invivyd, Inc.
BEARISH -82
SION $160M
Sionna Therapeutics, Inc.
BEARISH -82
CBUS $110M
Cibus, Inc.
BEARISH -82
VYGR $110M
Voyager Therapeutics, Inc.
BEARISH -82
VXRT $100M
Vaxart, Inc.
BEARISH -82
ENGN $100M
enGene Holdings Inc.
BEARISH -82
TNYA $90M
Tenaya Therapeutics, Inc.
BEARISH -82
HBPCF $60M
Helix BioPharma Corp.
BEARISH -82
PLRX $50M
Pliant Therapeutics, Inc.
BEARISH -82
KLRS $40M
Kalaris Therapeutics Inc
BEARISH -82
ALGS $30M
Aligos Therapeutics, Inc.
BEARISH -82
BYSI $20M
BeyondSpring Inc.
BEARISH -82
NEUP $20M
Neuphoria Therapeutics Inc.
BEARISH -82
PRRUF $20M
Immutep Limited
BEARISH -82
QNRX $10M
Quoin Pharmaceuticals, Ltd.
BEARISH -82
MSLE $10M
Satellos Bioscience Inc.
BEARISH -82
ANEB $10M
Anebulo Pharmaceuticals, Inc.
BEARISH -82
TCRX $10M
TScan Therapeutics, Inc.
BEARISH -82
FBLG $10M
FibroBiologics, Inc. Common Stock
BEARISH -82
CDIO $10M
Cardio Diagnostics Holdings, Inc.
BEARISH -82
APRE $10M
Aprea Therapeutics, Inc.
BEARISH -82
BCDA $10M
BioCardia, Inc.
BEARISH -82
HCWB —
HCW Biologics Inc.
BEARISH -82
USRM —
U.S. Stem Cell, Inc.
BEARISH -82
ARNI —
Arno Therapeutics, Inc.
BEARISH -82
ENZC —
Enzolytics Inc.
BEARISH -82
EVFM —
Evofem Biosciences, Inc.
BEARISH -82
BBLG —
Bone Biologics Corporation
BEARISH -82
MBIO —
Mustang Bio, Inc.
BEARISH -82
LIMN —
Liminatus Pharma, Inc. Class A Common Stock
BEARISH -82
BIOAF —
Bioasis Technologies Inc.
BEARISH -82
NCEL —
NewcelX Ltd.
BEARISH -82
SEPSF —
Asep Medical Holdings Inc
BEARISH -82
ENLV —
Enlivex Therapeutics Ltd.
BEARISH -82
ENDV —
Endonovo Therapeutics, Inc.
BEARISH -82
ARUXF —
Acrux Limited
BEARISH -82
MYNDF —
MYND Life Sciences Inc.
BEARISH -82
INBX $1.4B
Inhibrx Biosciences Inc.
BEARISH -84
SKYE $10M
Skye Bioscience, Inc.
BEARISH -84
PTIX —
Protagenic Therapeutics, Inc.
BEARISH -84
EMMA —
Emmaus Life Sciences, Inc.
BEARISH -84
PHRRF —
PharmaTher Holdings Ltd.
BEARISH -84
LIMNW —
Liminatus Pharma, Inc. Warrants
BEARISH -84
URGN $1.7B
UroGen Pharma Ltd.
BEARISH -87
MDCLF $1.1B
MedinCell S.A.
BEARISH -87
ANL $560M
Adlai Nortye Ltd.
BEARISH -87
GNFTF $470M
Genfit S.A.
BEARISH -87
ARTV $300M
Artiva Biotherapeutics, Inc.
BEARISH -87
TRGNF $120M
Transgene S.A.
BEARISH -87
PRNAF $50M
Alterity Therapeutics Limited
BEARISH -87
TVGN $30M
Tevogen Bio Holdings Inc.
BEARISH -87
BMNDF $20M
Biomind Labs Inc.
BEARISH -87
RMTG —
Regenerative Medical Technology Group Inc.
BEARISH -87
GENSF $1.8B
Genus plc
BEARISH -91
AGMB $450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH -91
AVCTF $420M
Avacta Group Plc
BEARISH -91
ALT $410M
Altimmune, Inc.
BEARISH -91
AVTX $370M
Avalo Therapeutics, Inc.
BEARISH -91
CAPR $340M
Capricor Therapeutics, Inc.
BEARISH -91
SPHDF $280M
Santhera Pharmaceuticals Holding AG
BEARISH -91
ORYZF $250M
Oryzon Genomics S.A.
BEARISH -91
OCGN $250M
Ocugen, Inc.
BEARISH -91
SCTX $250M
Scribe Therapeutics Inc.
BEARISH -91
HLOSF $240M
Healios K.K.
BEARISH -91
IPHYF $210M
Innate Pharma S.A.
BEARISH -91
NBP $160M
NovaBridge Biosciences
BEARISH -91
ZNTL $160M
Zentalis Pharmaceuticals, Inc.
BEARISH -91
STRO $150M
Sutro Biopharma, Inc.
BEARISH -91
NGEN $150M
NervGen Pharma Corp. Common stock
BEARISH -91
CMPX $140M
Compass Therapeutics, Inc.
BEARISH -91
CDXS $140M
Codexis, Inc.
BEARISH -91
NKTX $130M
Nkarta, Inc.
BEARISH -91
AVXL $120M
Anavex Life Sciences Corp.
BEARISH -91
VTVT $100M
vTv Therapeutics Inc.
BEARISH -91
VANI $100M
Vivani Medical, Inc.
BEARISH -91
ORPOF $100M
OSE Immunotherapeutics S.A.
BEARISH -91
TNXP $90M
Tonix Pharmaceuticals Holding Corp.
BEARISH -91
CNXU $90M
Conexeu Sciences Inc.
BEARISH -91
JWCTF $80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH -91
CRBP $80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH -91
CRDF $70M
Cardiff Oncology, Inc.
BEARISH -91
PTHS $70M
Pelthos Therapeutics Inc.
BEARISH -91
CGTX $70M
Cognition Therapeutics, Inc.
BEARISH -91
XBIT $60M
XBiotech Inc.
BEARISH -91
TLSA $60M
Tiziana Life Sciences Ltd
BEARISH -91
VTIAF $50M
FamiCord AG
BEARISH -91
HYFT $50M
MindWalk Holdings Corp.
BEARISH -91
EXOZ $40M
eXoZymes, Inc.
BEARISH -91
ACET $40M
Adicet Bio, Inc.
BEARISH -91
RANI $40M
Rani Therapeutics Holdings, Inc.
BEARISH -91
ALDX $40M
Aldeyra The
BEARISH -91
IXHL $30M
Incannex Healthcare Limited
BEARISH -91
AARD $30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH -91
BCTX $30M
BriaCell Therapeutics Corp.
BEARISH -91
FLNA $30M
Filana Therapeutics, Inc.
BEARISH -91
MGX $30M
Metagenomi, Inc. Common Stock
BEARISH -91
KYNB $20M
Kyntra Bio, Inc.
BEARISH -91
MVMDF $20M
More Life Company Corp.
BEARISH -91
TELIF $20M
Telescope Innovations Corp.
BEARISH -91
MCRB $20M
Seres Therapeutics, Inc.
BEARISH -91
ATYR $20M
aTyr Pharma, Inc.
BEARISH -91
TRAW $10M
Traws Pharma, Inc.
BEARISH -91
TOVX $10M
Theriva Biologics, Inc.
BEARISH -91
PTN $10M
Palatin Technologies, Inc.
BEARISH -91
GUTS $10M
Fractyl Health, Inc.
BEARISH -91
VTGN $10M
VistaGen Therapeutics, Inc.
BEARISH -91
OPTBF $10M
OptiBiotix Health Plc
BEARISH -91
TPST $10M
Tempest Therapeutics, Inc.
BEARISH -91
INAB $10M
IN8bio, Inc.
BEARISH -91
QNTM $10M
Quantum BioPharma Ltd.
BEARISH -91
IMNN $10M
Imunon, Inc.
BEARISH -91
GTBP $10M
GT Biopharma, Inc.
BEARISH -91
TVRD $10M
Tvardi Therapeutics, Inc.
BEARISH -91
PXXLF $10M
Poxel S.A.
BEARISH -91
DARE $10M
Dare Bioscience, Inc.
BEARISH -91
HIND $10M
Vyome Holdings, Inc.
BEARISH -91
GSGTF $10M
GenSight Biologics S.A.
BEARISH -91
OGEN —
Oragenics, Inc.
BEARISH -91
GSTC —
GlobeStar Therapeutics Corporation
BEARISH -91
SUVZ —
Suvanza Pharma, LLC
BEARISH -91
LABT —
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH -91
RADX —
Radiopharm Theranostics Limited
BEARISH -91
MBAI —
MBody AI Ltd.
BEARISH -91
EFTR —
eFFECTOR Therapeutics, Inc.
BEARISH -91
DCOY —
Decoy Therapeutics Inc.
BEARISH -91
RASP —
Actavia Life Sciences, Inc.
BEARISH -91
CLDI —
Calidi Biotherapeutics, Inc.
BEARISH -91
GNPX —
Genprex, Inc.
BEARISH -91
KALA —
KALA BIO, Inc.
BEARISH -91
TSOI —
Therapeutic Solutions International, Inc.
BEARISH -91
WSNAF —
Wesana Health Holdings Inc.
BEARISH -91
CEROW —
CERo Therapeutics Holdings, Inc.
BEARISH -91
NBRVF —
Nabriva Therapeutics plc
BEARISH -91
BNIGF —
Beroni Group Limited
BEARISH -91
SLXN —
Silexion Therapeutics Ltd.
BEARISH -91
ZVSA —
ZyVersa Therapeutics, Inc.
BEARISH -91
NIKI —
Niki BioSolutions, Inc.
BEARISH -91
BIXT —
Bioxytran, Inc.
BEARISH -91
GOVX —
GeoVax Labs, Inc.
BEARISH -91
TNGNQ —
Tengion, Inc.
BEARISH -91
XENO —
Xeno Transplants Corporation
BEARISH -91
ZHCLF —
Zenith Capital Corp.
BEARISH -91
MDCX —
Medicus Pharma Ltd. Common Stock
BEARISH -91
VPRO —
Viropro Inc.
BEARISH -91
PHMMF $1.6B
Pharma Mar, S.A.
BEARISH -100
BCAX $1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH -100
IVEVF $750M
Inventiva S.A.
BEARISH -100
INRLF $640M
Valneva SE
BEARISH -100
SPRY $400M
ARS Pharmaceuticals, Inc.
BEARISH -100
EIKN $390M
Eikon Therapeutics, Inc. Common Stock
BEARISH -100
DMTRF $310M
3-D Matrix, Ltd.
BEARISH -100
NERV $110M
Minerva Neurosciences, Inc.
BEARISH -100
VRCA $60M
Verrica Pharmaceuticals Inc.
BEARISH -100
ONCY $50M
Oncolytics Biotech Inc.
BEARISH -100
EDSA $30M
Edesa Biotech, Inc.
BEARISH -100
EYPT $30M
EyePoint Pharmaceuticals, Inc.
BEARISH -100
NRXBF $30M
NurExone Biologic Inc.
BEARISH -100
IGC $30M
IGC Pharma, Inc.
BEARISH -100
CRVO $30M
CervoMed Inc.
BEARISH -100
BSEM $30M
BioStem Technologies, Inc.
BEARISH -100
CNTX $20M
Context Therapeutics Inc.
BEARISH -100
BXPHF $20M
Botanix Pharmaceuticals Limited
BEARISH -100
ACXP $10M
Acurx Pharmaceuticals, Inc.
BEARISH -100
RDTCF $10M
Rapid Dose Therapeutics Corp.
BEARISH -100
BLRX $10M
BioLineRx Ltd.
BEARISH -100
ACTU $10M
Actuate Therapeutics Inc
BEARISH -100
AIMD $10M
Ainos, Inc.
BEARISH -100
KTTA $10M
Pasithea Therapeutics Corp.
BEARISH -100
RVPH $10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH -100
MTVA $10M
MetaVia Inc.
BEARISH -100
CODX —
Co-Diagnostics, Inc.
BEARISH -100
NAVBQ —
Navidea Biopharmaceuticals, Inc.
BEARISH -100
HLUN —
HEALTHeUNIVERSE, Inc.
BEARISH -100
FAMDF —
Futura Medical plc
BEARISH -100
KAPA —
Kairos Pharma, Ltd.
BEARISH -100
APVO —
Aptevo Therapeutics Inc.
BEARISH -100
NSHSF —
NanoSphere Health Sciences Inc.
BEARISH -100
CANF —
Can-Fite BioPharma Ltd.
BEARISH -100
PPBT —
Purple Biotech Ltd.
BEARISH -100
BXRXQ —
Baudax Bio, Inc.
BEARISH -100
NRSN —
NeuroSense Therapeutics Ltd.
BEARISH -100
NMLSF —
Restart Life Sciences Corp.
BEARISH -100
ZLDAF —
Zelira Therapeutics Limited
BEARISH -100
PMCB —
PharmaCyte Biotech, Inc.
BEARISH -100
OXBOF —
Oxford BioDynamics Plc
BEARISH -100
CELZ —
Creative Medical Technology Holdings, Inc.
BEARISH -100
XSNX —
NovAccess Global Inc.
BEARISH -100

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
VNDA Vanda Pharmaceuticals Inc. $240M -0.9 -77.8 -201.0 -123.7 6.0 3 BEARISH -28.7
SEPN Septerna Inc $1.9B -81.9 -6.3 -93.1 -48.7 17878.5 5 BULLISH 95.6
KLRA Kailera Therapeutics, Inc. $1.7B — — — — — — BULLISH —
COAG Hemab Therapeutics Holdings, Inc. Common Stock $1.6B — — — — — — BULLISH —
REPL Replimune Group, Inc. $1.1B -5.8 -115.8 -882.8 — — 3 BULLISH 72.1
RIGL Rigel Pharmaceuticals, Inc. $900M 2.9 126.9 88.5 22.0 3.3 4 BULLISH 71.5
SOLTF Nxera Pharma Co., Ltd. $770M -16.4 -12.0 -1.7 -2.6 7.5 4 BULLISH 38.2
CRMD CorMedix Inc. $610M 3.4 54.9 57.2 25.5 280.5 5 BULLISH -25.8
DMAC DiaMedica Therapeutics Inc. $470M -13.6 -114.6 616.3 — — 2 BULLISH 42.7
SGMT Sagimet Biosciences Inc. $310M -8.4 -24.4 -231.4 — — 3 BULLISH 24.9
DTIL Precision BioSciences, Inc. $180M -2.7 -135.1 203.1 — 3473.0 5 BULLISH 4.0
MXCT MaxCyte, Inc. $140M -5.1 -20.4 -38.9 -122.0 -13.2 2 BULLISH 11.0
PYPD PolyPid Ltd. $110M -3.9 -1913.8 231.6 — — 3 BULLISH 60.1
ANIX Anixa Biosciences, Inc. $100M -11.0 -67.1 -1110.2 — — 3 BULLISH -22.2
NNVC NanoViricides, Inc. $40M -3.5 -101.5 -111.4 — — 3 BULLISH -9.9
VIR Vir Biotechnology, Inc. $1.8B -6.4 -26.1 -38.8 33.5 1495.9 5 BULLISH 92.7
SGP SpyGlass Pharma, Inc. Common Stock $950M — — — — — — BULLISH —
VSTM Verastem, Inc. $910M -4.0 -471.2 6197.3 -86.5 3995.7 4 BULLISH 12.8
ATNM Actinium Pharmaceuticals, Inc. $50M 3.8 45.9 -197.8 79.7 — 3 BULLISH -9.8
GRDX GridAI Technologies Corp. $40M -1.3 -55.6 -51.7 -14927.4 67.4 2 BULLISH 40.8
MAZE Maze Therapeutics, Inc. $1.7B -11.6 -37.3 -112.3 — — 3 BULLISH 2.4
PRME Prime Medicine, Inc. $670M -4.9 -373.3 -271.3 -3649.0 -17.9 3 BULLISH 4.1
XFOR X4 Pharmaceuticals, Inc. $320M -2.8 -113.1 -281.1 -183.5 -51.6 4 BULLISH -10.4
LYEL Lyell Immunopharma, Inc. $230M -0.7 -93.3 -227.7 -1118875.0 -55.0 3 BULLISH -36.6
ZIVO ZIVO Bioscience, Inc. $20M -5.2 185.9 147.5 — -62.5 2 BULLISH -50.1
PVLA Palvella Therapeutics, Inc. $1.8B -30.5 -46.6 137.5 — — 3 BULLISH 109.4
RARE Ultragenyx Pharmaceutical Inc. $1.5B -2.9 839.4 -67.5 -43.0 17.5 2 BULLISH -51.3
OABIW OmniAb, Inc. $1.1B -14.7 -16.9 -16.8 -43.7 66.9 6 BULLISH -14.0
EDIT Editas Medicine, Inc. $370M -3.9 -118.8 71.4 -153.3 20.8 4 BULLISH -9.2
INDP Indaptus Therapeutics, Inc. $360M -0.5 -318.0 6437.4 — — 4 BULLISH -6.2
KRRO Korro Bio, Inc. $180M -1.4 -97.7 -196.6 — -62.1 2 BULLISH -65.0
PCSA Processa Pharmaceuticals, Inc. $10M -0.3 -464.2 1977.5 — — 2 BULLISH -76.2
IRLA IRulya Therapeutics Inc. $30M — — — — — — BULLISH —
GENB Generate Biomedicines, Inc. $1.6B -9.1 -28.2 -175.0 -1065.2 — 1 BULLISH —
RXRX Recursion Pharmaceuticals, Inc. $2.0B -4.2 -56.6 -99.7 -1708.0 -14.9 4 BULLISH -30.9
CING Cingulate Inc. $70M -1.0 -198.7 -1452.8 — — 4 BULLISH 39.6
ESLA Estrella Immunopharma, Inc. $40M -3.3 148.1 102.1 — — 3 BULLISH -64.0
ABSI Absci Corporation $1.6B -14.8 -57.7 -213.1 -10443.4 -62.3 5 BULLISH 164.0
TRAX First Tracks Biotherapeutics Inc $1.6B — — — — — — BULLISH —
NTLA Intellia Therapeutics, Inc. $1.6B -4.0 -55.4 -92.1 -1392.3 12.6 5 BULLISH -10.0
LBRX LB Pharmaceuticals Inc Common Stock $1.2B -13.4 -25.8 -768.9 — — 2 BULLISH 138.5
ENTX Entera Bio Ltd. $510M -8.9 -138.9 314.4 — -100.0 1 BULLISH 33.0
KROS Keros Therapeutics, Inc. $220M -3.1 -17.2 -392.2 — -93.6 3 BULLISH -22.8
HURA TuHURA Biosciences, Inc. $140M -3.7 -161.4 -137.6 — — 2 BULLISH -13.5
NRXS NeurAxis, Inc. $90M -9.8 -143.2 464.1 -118.1 65.2 6 BULLISH 143.4
HOWL Werewolf Therapeutics, Inc. $50M -1.4 -119.9 354.7 17.5 — 4 BULLISH -36.1
PRLD Prelude Therapeutics Incorporated $210M -5.2 -57.7 14236.3 -244.1 220.3 5 BULLISH 142.1
NAUT Nautilus Biotechnolgy, Inc. $410M -7.0 -41.0 -89.2 -6682.1 — 2 BULLISH 137.8
PRTA Prothena Corporation plc $420M -11.0 -14.4 -871.5 -1839.9 427.3 5 BULLISH -12.2
GLSI Greenwich LifeSciences, Inc. $240M -11.9 -951.6 299.9 — — 2 BULLISH 87.0
SRPT Sarepta Therapeutics, Inc. $1.9B -13.4 -9.5 -6.3 -1.2 -20.4 4 BULLISH -17.8
XNCR Xencor, Inc. $1.9B -13.8 -29.1 -152.4 -42.4 -36.1 2 BULLISH 110.2
XERS Xeris Biopharma Holdings, Inc. $1.9B -109.6 118.2 18.3 -33.8 36.3 6 BULLISH 14.3
SPTX Seaport Therapeutics, Inc. Common Stock $1.1B — — — — — — BULLISH —
SLN Silence Therapeutics plc $930M -5.2 -90.4 157.8 — -97.6 1 BULLISH 176.1
ADCT ADC Therapeutics S.A. $180M -2.4 45.3 260.9 -86.1 2.0 2 BULLISH -62.2
ICCC ImmuCell Corporation $90M 125.5 2.6 10.2 25.5 8.5 6 BULLISH 70.2
ADIL Adial Pharmaceuticals, Inc. $10M -0.3 -2011.6 159.6 — — 3 BULLISH -43.0
MBRX Moleculin Biotech, Inc. $10M -0.0 -1371.6 -494.1 — — 3 BULLISH -27.8
ABPO Abpro Holdings, Inc. — — — — — — — BULLISH —
PDSB PDS Biotechnology Corporation $60M -2.4 -544.0 456.9 — — 1 BULLISH 62.8
AGTX Agentix Corp. — -5.1 12.0 8.1 — — 3 BULLISH 6.0
NBTX Nanobiotix S.A. $1.5B -27.6 104.2 62.0 -626.0 49.1 4 BULLISH 125.3
MLTX MoonLake Immunotherapeutics $1.0B -3.2 -67.4 2902.7 — — 1 BULLISH 22.2
PLUR Pluri Inc. $10M -0.5 163.6 -483.9 -1755.2 -24.0 2 BULLISH -68.5
BOLT Bolt Biotherapeutics, Inc. $10M -0.4 -111.6 -138.8 -154400.0 12.8 3 BULLISH 5.5
BDRX Biodexa Pharmaceuticals Plc — -77.8 -42.3 -117.9 — — 2 BULLISH -88.9
CBDG THC Farmaceuticals, Inc. — -30.9 2.0 -0.9 — 28.1 5 BULLISH -63.1
KNBIF Kane Biotech Inc. — -2.4 439.7 -2166.6 -10238.1 -97.9 2 BULLISH -22.4
STOK Stoke Therapeutics, Inc. $1.6B -7.9 -61.1 -318.5 -660.8 -86.2 2 BULLISH -20.0
PHAR Pharming Group N.V. $710M 34.4 3.6 3.2 1.8 7.8 7 BULLISH -8.0
CCCC C4 Therapeutics, Inc. $380M -3.4 -48.1 -175.0 -355.9 2.3 4 BULLISH 28.3
NGNE Neurogene Inc. $370M -5.5 -45.3 -111469.0 — — 2 BULLISH -5.1
FENC Fennec Pharmaceuticals Inc. $350M -83.6 -18.6 -76.2 11.0 77.8 6 BULLISH 23.2
ALEC Alector, Inc. $200M -2.0 -385.1 66.8 -692.5 -82.9 1 BULLISH 50.0
OKYO OKYO Pharma Limited $70M -6.2 -263.8 88.0 — — 3 BULLISH -43.8
PBYI Puma Biotechnology, Inc. $570M 19.8 22.0 52.8 14.5 -2.9 6 BULLISH 101.5
AZTR Azitra, Inc. — -0.1 -256.7 -959.6 — — 5 BULLISH 65.7
BCYC Bicycle Therapeutics plc $250M -1.4 -32.3 -1197.0 -8002.1 217.4 4 BULLISH -52.2
LCTX Lineage Cell Therapeutics, Inc. $250M -7.4 -59.0 -171.3 138.6 19.9 5 BULLISH -41.1
IMCR Immunocore Holdings plc $1.6B -180.9 -2.3 -472.0 -0.7 13.4 4 BULLISH -2.5
JANX Janux Therapeutics, Inc. $1.0B -10.9 -10.7 516.9 -214.0 7162.0 4 BULLISH -34.0
ACOG Alpha Cognition Inc $130M -8.4 -55.3 -198.4 -144.3 232.7 2 BULLISH 14.6
SCNLF Scancell Holdings plc $170M -5.1 153.2 179.2 — -100.0 2 BULLISH 969.8
PULM Pulmatrix, Inc. $10M -1.4 -98.3 -835.1 — -100.0 3 BULLISH -69.6
TCRT Alaunos Therapeutics, Inc. $10M -1.1 -185.9 -607.2 — -50.0 1 BULLISH -27.3
CLGN CollPlant Biotechnologies Ltd. — -0.4 -162.0 -369.3 -2524.1 -86.8 2 BULLISH -83.0
ZBIO Zenas BioPharma, Inc. $1.8B -3.0 -199.0 5842.1 -11145.6 -93.3 2 BULLISH -9.5
VOR Vor Biopharma Inc. $990M 0.1 -73.6 22.2 — — 3 BULLISH -26.6
DRUG Bright Minds Biosciences Inc. $520M -26.8 -13.7 -105758.3 — — 3 BULLISH -5.9
ELDN Eledon Pharmaceuticals, Inc. $190M -2.8 -110.7 411.1 — — 2 BULLISH -27.9
ABOS Acumen Pharmaceuticals, Inc. $140M -1.5 -162.7 466.8 — — 2 BULLISH 8.2
PMN ProMIS Neurosciences, Inc. $70M -0.7 -172.3 844.3 — — 2 BULLISH -3.4
HEPA Hepion Pharmaceuticals, Inc. — -0.6 -125.6 710.2 — — 3 BULLISH 130.8
ACUT Accustem Sciences Inc. — -1.4 49.7 34.0 -256.7 2610.7 4 BULLISH -88.8
NXTC NextCure, Inc. $20M -0.6 -195.2 949.7 — — 2 BULLISH -31.6
KPTI Karyopharm Therapeutics Inc. $10M -0.0 79.0 36.3 -200.5 6.8 2 BULLISH -87.0
HALB Halberd Corporation — -25.4 11.6 12.4 — -52.1 1 BULLISH -18.6
BRVE Braveheart Bio, Inc. $1.5B — — — — — — BULLISH —
DMRA Damora Therapeutics, Inc. $1.3B — — — — — — BULLISH —
PTCHF PureTech Health plc $390M 156.5 0.2 50.8 1890.6 7.7 4 BULLISH -5.4
IPIX Innovation Pharmaceuticals Inc. — -0.2 -115.7 -377.9 — -133.3 3 BULLISH 25.0
TYRA Tyra Biosciences, Inc. $1.2B -9.1 -45.3 -2390.9 — — 2 BULLISH 46.6
ARVN Arvinas, Inc. $470M 40.0 1.6 -519.3 67.8 -15.0 4 BULLISH -21.2
DBVT DBV Technologies S.A. $230M -2.7 -142.6 -2201.5 — -100.0 2 BULLISH -33.4
TIL Instil Bio, Inc. $40M -1.5 -25.3 -69.1 — — 4 BULLISH -65.8
MDNAF Medicenna Therapeutics Corp. $20M — — — — — — BULLISH —
OBX Obsidian Therapeutics Inc. $10M — — — — — — BULLISH —
CALC CalciMedica, Inc. — -0.2 -365.7 118.3 — — 4 BULLISH -89.0
KURA Kura Oncology, Inc. $850M -3.2 -167.7 56.3 -327.3 -7.3 1 BULLISH -2.9
RZLT Rezolute, Inc. $370M -5.6 -59.0 1060.6 — — 2 BULLISH -55.2
OBIO Orchestra BioMed Holdings, Inc. $340M -6.1 -397.3 468.3 -26994.3 986.1 4 BULLISH 51.6
PEPG PepGen Inc. $170M -1.7 -75.5 -327.5 — — 4 BULLISH -53.4
DNA Ginkgo Bioworks Holdings, Inc. $670M -2.7 -56.3 -44.0 -231.7 -51.5 2 BULLISH -0.4
QURE uniQure N.V. $1.6B -6.2 -157.6 37.9 -1387.8 30.2 4 LEAN BULL -63.2
BCRX BioCryst Pharmaceuticals, Inc. $1.9B -5.8 87.8 62.3 35.9 68.7 5 LEAN BULL 14.5
CMPS COMPASS Pathways plc $1.6B -2.2 -319.1 48.8 — — 2 LEAN BULL 87.8
OVID Ovid Therapeutics Inc. $420M -5.1 -26.0 -43.7 -2047.6 -76.2 3 LEAN BULL 53.1
SABS SAB Biotherapeutics, Inc. $260M 0.9 -11.3 -48.4 — -100.0 3 LEAN BULL 5.6
CLNN Clene Inc. $60M -1.1 237.2 132.5 -14915.6 -31.1 2 LEAN BULL -52.6
BIVI BioVie Inc. $10M -0.5 -0.0 -0.0 — — 3 LEAN BULL -22.8
INFIQ Infinity Pharmaceuticals, Inc. — -0.0 109.5 60.9 -1707.7 — 2 LEAN BULL 0.0
ARDS Aridis Pharmaceuticals, Inc. — -0.0 4.8 10.0 -19.9 2227.6 4 LEAN BULL -86.2
BSSP Baseline Productions, Inc. — -0.0 167.7 64.9 — — 2 LEAN BULL 19900.0
VCRE Vicore Pharma Holding AB $260M — — — — — — LEAN BULL —
INKT MiNK Therapeutics, Inc. $50M -4.5 57.9 42.8 — — 4 LEAN BULL -24.0
CKDXF Ceryvyn Therapeutics Ltd $10M 0.1 -243.9 2882.8 — -97.3 3 LEAN BULL -97.6
CYYNF Cynata Therapeutics Limited — -0.3 -326.4 584.9 — -100.0 1 LEAN BULL -93.9
VAXX Vaxxinity, Inc. — -0.2 -150.6 2534.7 — — 0 LEAN BULL 2699900.0
ANAB AnaptysBio, Inc. $1.5B 7.5 -1146.3 466.0 668.9 92.9 5 LEAN BULL 109.4
IMRX Immuneering Corporation $240M -3.8 -52.1 -112.8 — — 4 LEAN BULL -36.7
INVA Innoviva, Inc. $1.5B 4.3 36.7 15.0 -69.8 19.8 7 LEAN BULL 19.2
YDES YD Bio Limited Ordinary Shares $350M — — — — — — LEAN BULL -62.1
ZURA Zura Bio Limited $320M -3.9 -65.4 806.5 — — 2 LEAN BULL 10.7
FATE Fate Therapeutics, Inc. $250M -2.1 -60.7 -140.1 -1448.6 -23.4 2 LEAN BULL 114.8
MDWD MediWound Ltd. $150M -8.5 -72.4 -255.1 -239.1 -40.3 2 LEAN BULL -26.3
RNXT RenovoRx, Inc. $60M -4.5 -125.2 4391.9 -320.2 198.5 3 LEAN BULL 24.4
VSBC VitaSpring Biomedical Co. Ltd. $10M -13.8 10.3 15.9 — -100.0 4 LEAN BULL -96.8
LOBEF Lobe Sciences Ltd. $10M -2.7 359.0 181.6 — — 2 LEAN BULL 33.1
PXMD PaxMedica, Inc. Common Stock — -0.0 -7716.2 572.1 — — 2 LEAN BULL 600.0
SCPX Scorpius Holdings, Inc. — -0.0 0.0 0.0 -428.3 -75.5 0 LEAN BULL -45.5
REVB Revelation Biosciences, Inc. — -0.1 -154.8 1317.2 — — 4 LEAN BULL 176.7
IUGNF Imugene Limited $30M -0.1 -389.5 -458.5 — -100.0 1 LEAN BULL -82.1
CURX Curanex Pharmaceuticals Inc Common Stock $10M -0.7 -218.7 -392.2 — — 1 LEAN BULL -69.1
ACRS Aclaris Therapeutics, Inc. $550M -6.8 -59.1 -206.5 -1320.1 -51.0 3 LEAN BULL 69.2
RNA Atrium Therapeutics, Inc. $140M -2.2 -36.9 455.9 -672.0 235.3 5 LEAN BULL -82.9
TXTM ProText Mobility, Inc. $90M 72.0 -0.4 -0.3 — -100.0 1 LEAN BULL 191.4
CLCS Cell Source, Inc. $40M -5.3 27.7 34.5 — — 4 LEAN BULL 41.3
SRZN Surrozen, Inc. $190M -0.7 387.2 11.1 1003.5 -8.8 2 LEAN BULL 117.9
ANTX AN2 Therapeutics, Inc. $130M -4.2 -50.1 1243.3 — — 2 LEAN BULL 234.8
PBLA Panbela Therapeutics, Inc. — -0.0 270.3 240.0 — 100.0 3 LEAN BULL 0.0
NMAD NOMAD Power Solutions, Inc. $50M — — — — — — LEAN BULL —
WVE Wave Life Sciences Ltd. $630M -3.4 -80.0 -1243.7 -470.5 -35.1 2 LEAN BULL -52.2
SPRB Spruce Biosciences, Inc. $130M -1.1 -106.0 772.2 — -100.0 4 LEAN BULL -61.8
ZEOX Zeo ScientifiX, Inc. $10M -2.1 -140.0 105.8 -5.6 — 2 LEAN BULL —
ENSC Ensysce Biosciences, Inc. $10M -0.2 -968.3 792.9 -220.8 -77.6 3 LEAN BULL -78.9
NWBO Northwest Biotherapeutics, Inc. $260M -6.8 55.8 -188.7 -1142.6 98.6 3 LEAN BULL -34.9
CHRS Coherus Oncology, Inc. $160M -1.1 -145.4 1854.0 -144.2 -64.3 2 LEAN BULL -27.5
OKUR OnKure Therapeutics, Inc. $100M -0.8 -46.9 1464.5 — — 4 LEAN BULL -26.3
EHOS Ehouse Global, Inc. — -0.0 161.0 52.5 — — 1 LEAN BULL 0.0
BETRF BetterLife Pharma Inc. $110M -10.9 34.9 21.6 — — 4 LEAN BULL 282.3
LITS Lite Strategy, Inc. $40M -0.1 -170.9 -28.2 — — 2 LEAN BULL -41.1
LEXX Lexaria Bioscience Corp. $10M -0.6 -150.3 -504.2 — -68.5 4 LEAN BULL -78.0
ENVB Enveric Biosciences, Inc. $10M -0.1 -170.0 3225.6 — — 4 LEAN BULL -80.1
NMTRQ 9 Meters Biopharma, Inc. — — — — — — — LEAN BULL 9900.0
CMRA Comera Life Sciences Holdings, Inc. — -0.0 235.6 124.2 -1580.0 81.8 4 LEAN BULL 0.0
DNAG DNAPrint Genomics, Inc. — -0.0 63.1 -156.0 -826.7 -15.2 3 LEAN BULL 100.0
ONCSQ OncoSec Medical Incorporated — -0.0 -410.2 452.1 — — 2 LEAN BULL -90.0
ABVC ABVC BioPharma, Inc. $30M -3.7 -82.2 -43.0 — -100.0 2 NEUTRAL -62.3
IFRX InflaRx N.V. $230M -3.2 -38.5 251.5 — -106.2 4 NEUTRAL 4.2
LONA LeonaBio, Inc. $20M — — — — — — NEUTRAL —
ADXN Addex Therapeutics Ltd — -0.4 -150.5 -168.4 -17543.0 -48.1 2 NEUTRAL -69.7
CYDY CytoDyn Inc. $380M -4.8 57.8 24.6 — 100.0 4 NEUTRAL -16.7
CGEM Cullinan Therapeutics, Inc. $880M -4.6 -50.3 1635.6 — — 1 NEUTRAL 93.0
QTTB Q32 Bio Inc. $260M 3.2 72.1 435.2 — — 5 NEUTRAL 223.6
EVMN Evommune, Inc. $190M -1.9 -29.6 -82.4 — — 2 NEUTRAL —
GBIM GlobeImmune, Inc. — -0.0 -66.2 25.0 -91.5 55.1 4 NEUTRAL 0.0
OCEA Ocean Biomedical, Inc. — -0.0 36.5 0.3 — — 1 NEUTRAL -20.0
BPTH Bio-Path Holdings, Inc. — -0.0 49.0 15.2 — -100.0 1 NEUTRAL -99.7
CARM Carisma Therapeutics, Inc. — 0.0 -134.1 -376.4 98.8 159.7 3 NEUTRAL -98.8
FULC Fulcrum Therapeutics, Inc. $280M -3.1 -32.4 2389.1 — — 4 NEUTRAL -61.1
FHTX Foghorn Therapeutics Inc. $120M -2.2 81.9 26.3 -44.7 52.0 4 NEUTRAL -48.3
RNTX Rein Therapeutics Inc. $50M -0.4 -753.6 53.9 — — 3 NEUTRAL -47.1
GDTC CytoMed Therapeutics Limited $10M -2.7 -66.1 -87.8 -1125.6 -11.3 0 NEUTRAL -61.4
ONCO Onconetix, Inc. — -0.1 -105.2 -83.7 -16748.3 -51.3 3 NEUTRAL -83.2
HESG Health Sciences Group, Inc. — -0.0 69.4 44.6 -19219.1 101.6 3 NEUTRAL 900.0
NTRR Neutra Corp. — 2.0 -139.6 -802.5 -3.8 142.2 7 NEUTRAL 0.0
STTK Shattuck Labs, Inc. $550M -11.4 -39.2 -29.3 — -66.6 4 NEUTRAL 182.0
ARCT Arcturus Therapeutics Holdings Inc. $280M -3.6 -46.3 -2501.0 -803.8 -79.1 1 NEUTRAL 14.0
CTXR Citius Pharmaceuticals, Inc. $10M -0.3 -70.3 -85.4 -593.3 4456.8 3 NEUTRAL -66.6
NKGN NKGen Biotech, Inc. — -0.0 150.9 — -4511.3 — 3 NEUTRAL -45.0
YDESW YD Bio Limited Warrants — — — — — — — NEUTRAL -69.0
CFRXQ ContraFect Corp. — -0.0 544.7 276.9 — — 1 NEUTRAL -90.0
RBSH Rebus Holdings, Inc. — -0.0 -9.7 8.9 — — 2 NEUTRAL 0.0
LYCA Lycia Therapeutics Inc. $1.6B — — — — — — N/A —
CTY City Therapeutics Inc. $200M — — — — — — N/A —
IAM Iambic Therapeutics Inc. $130M — — — — — — N/A —
ACHFF Arch Biopartners Inc. $40M -19.3 73.5 165.4 — 100.0 2 NEUTRAL -15.7
ATOS Atossa Therapeutics, Inc. $30M -0.5 -89.2 -4213.1 — — 2 NEUTRAL -83.2
ODTX Odyssey Therapeutics, Inc. $940M — — — — — — NEUTRAL —
JBIO Jade Biosciences, Inc. $930M -5.3 -47.8 629.9 — — 3 NEUTRAL 43.2
SVRA Savara Inc. $870M -8.7 -105.5 -15438.9 — — 2 NEUTRAL 14.6
SNGX Soligenix, Inc. $10M -0.3 -241.7 304.6 — — 4 NEUTRAL -83.9
KLDO Kaleido Biosciences, Inc. — -0.0 -591.2 1121.9 -4292.5 13.2 2 NEUTRAL 0.0
ALMS Alumis Inc. $880M -1.9 -93.6 2645.2 -8557.2 -63.1 2 NEUTRAL 48.2
YARW Yarrow Bioscience Inc $180M — — — — — — NEUTRAL —
EQ Equillium, Inc. $80M -5.5 -59.0 2703.6 — -100.0 3 NEUTRAL 3.6
ELTX Elicio Therapeutics, Inc. $40M -0.9 -774.6 2147.3 — — 4 NEUTRAL -80.9
NYMXF Nymox Pharmaceutical Corporation $10M -0.7 193.9 89.4 — — 2 NEUTRAL -70.0
RVLPQ RVL Pharmaceuticals plc — -0.0 -182.4 -101.1 -289.3 5.6 3 NEUTRAL 900.0
WHWK Whitehawk Therapeutics Inc $180M -3.1 -45.0 963.4 — -100.0 1 NEUTRAL 43.0
PYXS Pyxis Oncology, Inc. $110M -1.4 -179.1 1953.9 — 291.4 2 NEUTRAL -41.6
ELUT Elutia Inc $40M 0.6 -397.0 -290.2 -315.0 -48.8 6 NEUTRAL -6.7
EVAX Evaxion Biotech A/S $20M -0.5 -109.8 -260.4 — 135.9 6 NEUTRAL -49.3
LADX LadRx Corporation — -0.0 278.9 118.4 — -61.0 1 NEUTRAL -99.0
MRPI Mera Pharmaceuticals, Inc. — -10000.0 24.3 18.3 -159.9 4.8 5 NEUTRAL 0.0
MBXBF Microbix Biosystems Inc. $30M -8.2 -16.4 -14.6 -19.9 -27.1 3 LEAN BEAR 24.3
XBIO Xenetic Biosciences, Inc. — -1.8 -47.0 523.4 -140.7 33.3 4 LEAN BEAR -44.0
MLLCF Molecular Partners AG $150M -2.2 -62.1 650.3 — -100.0 2 LEAN BEAR 14.6
POLBF Poolbeg Pharma PLC $70M -8.5 -58.8 -255.9 — — 1 LEAN BEAR 125.4
CLYYF Celyad Oncology S.A. $10M 2.5 -11.7 -979.7 64360.6 -88.7 5 LEAN BEAR 40.0
QPTFF Quest PharmaTech Inc. $10M 1.6 3.9 -1.7 — — 4 LEAN BEAR 125.6
CAMP CAMP4 Therapeutics Corporation $210M -1.6 -545.9 48.4 -1884.8 40.2 2 LEAN BEAR -6.4
ENTA Enanta Pharmaceuticals, Inc. $340M -4.8 -70.1 141.5 -135.8 0.7 4 LEAN BEAR 10.0
AGEN Agenus Inc. $290M 2.6 -33.2 -20.4 -1.6 30.5 6 LEAN BEAR 71.8
BIOA BioAge Labs Inc. $190M -2.5 -28.2 -142.3 -1064.7 168.1 4 LEAN BEAR -22.1
ALXO ALX Oncology Holdings Inc. $160M -1.0 -80.6 -851.1 — — 4 LEAN BEAR -30.6
AURX Nuo Therapeutics, Inc. $60M -31.1 170.6 280.3 -15.7 166.6 3 LEAN BEAR -45.8
JSPR Jasper Therapeutics, Inc. $20M -0.3 -255.0 773.9 — — 2 LEAN BEAR -76.9
CNBX CNBX Pharmaceuticals Inc. — -0.5 17.8 13.3 — 100.0 3 LEAN BEAR -66.7
GYRE Gyre Therapeutics, Inc. $620M -35.6 -15.6 -22.3 -36.4 16.8 3 LEAN BEAR -11.6
NTRB Nutriband Inc. $70M -11.2 -100.7 -264.9 -201.3 -37.3 3 LEAN BEAR -9.0
BOLD Boundless Bio, Inc. $50M -0.9 -67.9 807.9 — — 2 LEAN BEAR 67.8
AEON AEON Biopharma, Inc. $10M -0.1 350.0 98.0 — — 2 LEAN BEAR -71.0
SRBCF Sirona Biochem Corp. — -0.7 111.4 1025.7 -34808.5 -119.4 2 LEAN BEAR -50.5
SNNAQ Sienna Biopharmaceuticals, Inc. — -0.0 -140.9 -331.4 — — 2 LEAN BEAR 0.0
PPCB Propanc Biopharma, Inc. — -0.1 -161.9 -166.7 — — 4 LEAN BEAR 45.3
IMVIF IMV Inc. — -0.2 -503.3 -2870.5 — — 1 LEAN BEAR 1900.0
MCET MultiCell Technologies, Inc. — -0.1 101.2 99.1 -81.8 1532.7 5 LEAN BEAR 900.0
TRVI Trevi Therapeutics, Inc. $1.8B -40.0 -19.7 -1451.7 — — 3 LEAN BEAR 28.8
AURA Aura Biosciences, Inc. $650M -3.6 -53.5 -1360.0 — — 4 LEAN BEAR 4.9
TTRX Turn Therapeutics Inc. $310M -38.2 -952.4 115.0 — — 2 LEAN BEAR 123.7
MMIRF MedMira Inc. $30M -11.4 11.8 21.7 -200.5 45.7 4 LEAN BEAR -20.4
SLDB Solid Biosciences Inc. $630M -3.4 -65.5 -1012.6 — — 3 LEAN BEAR 9.8
XTLB XTL Biopharmaceuticals Ltd. — -0.6 -26.8 -38.7 -88.2 — 3 LEAN BEAR 67.5
LYRA Lyra Therapeutics, Inc. — -0.0 -6595.0 -671.6 -99300.0 -74.1 4 LEAN BEAR -97.6
PARD Poniard Pharmaceuticals, Inc. — -0.0 -210.4 -442.5 — — 3 LEAN BEAR 0.0
STAB Statera Biopharma, Inc. — -0.0 -298.8 2085.4 -769.5 1459.1 3 LEAN BEAR -50.0
AOBI American Oriental Bioengineering, Inc. — -0.0 -28.2 -16.5 -118.1 -10.2 3 LEAN BEAR 983.3
HSTC HST Global, Inc. $210M -538.5 -2.5 -1.2 -13.7 564.0 5 LEAN BEAR 349900.0
TSHA Taysha Gene Therapies, Inc. $1.3B -10.0 -47.1 961.0 — -32.3 3 LEAN BEAR -13.1
CLLS Cellectis S.A. $100M -1.9 -94.6 118.6 -417.3 0.5 2 LEAN BEAR -65.3
IMUX Immunic, Inc. $100M -1.7 -138.2 345.6 — — 5 LEAN BEAR -4.4
GRCE Grace Therapeutics, Inc. $30M -1.6 -38.4 -58.9 — — 2 LEAN BEAR -36.2
PBIGF Paradigm Biopharmaceuticals Limited $10M -1.6 -456.6 1081.8 -60158.9 53.6 4 LEAN BEAR -96.1
PREDQ Predictive Discovery Limited — — — — — — — LEAN BEAR —
MNKD MannKind Corporation $1.0B -24.6 71.4 4.0 -17.4 30.5 2 LEAN BEAR -36.7
RCKT Rocket Pharmaceuticals, Inc. $250M -16.1 -4.8 -137.8 — — 3 LEAN BEAR -34.5
CSBR Champions Oncology, Inc. $70M -62.3 -30.7 -7.8 -2.8 6.7 3 LEAN BEAR -27.9
GOSS Gossamer Bio, Inc. $60M -0.2 178.7 117.2 182.9 32.4 3 LEAN BEAR -94.4
KARD Kardigan, Inc. $1.1B — — — — — — LEAN BEAR —
FDMT 4D Molecular Therapeutics, Inc. $600M -4.8 -43.3 -182.0 -1929.0 278712.1 4 LEAN BEAR 5.4
RNAC Cartesian Therapeutics, Inc. $190M -1.1 241.0 37.3 — 44.0 2 LEAN BEAR -24.4
CGEN Compugen Ltd. $180M 5.4 49.6 -90.2 -269.3 886.7 5 LEAN BEAR 17.5
TRDA Entrada Therapeutics, Inc. $170M -1.2 -54.1 -236.6 -4762.0 -94.1 1 LEAN BEAR -33.8
BDTX Black Diamond Therapeutics, Inc. $110M -2.5 -37.2 -1604.9 — -100.0 1 LEAN BEAR -53.7
NTHI Neonc Technologies Holdings, Inc. $90M — — — — — — LEAN BEAR -63.2
SGMOQ Sangamo Therapeutics, Inc. $50M — — — — — — LEAN BEAR —
PZRXQ PhaseRx, Inc. — -0.0 -228.2 8803.4 — — 2 LEAN BEAR 0.0
RNAZ TransCode Therapeutics, Inc. — -0.0 -59.2 -21.0 — — 1 LEAN BEAR -86.5
REPCF RepliCel Life Sciences Inc. — -9.4 -248.8 -13.9 -80.9 200.0 6 LEAN BEAR 0.0
NNBP Nanobac Pharmaceuticals, Incorporated — 0.0 358.0 221.2 -26718.6 -92.2 3 LEAN BEAR 0.0
NNLX NanoLogix, Inc. — — — — — — — LEAN BEAR -20.0
CLAZF Claritas Pharmaceuticals, Inc. — 0.0 -170.1 15.9 — — 3 LEAN BEAR 0.0
GWIN Glorywin Entertainment Group, Inc. $360M -26081.4 11.7 5.1 — — 1 LEAN BEAR 229.5
FGHQF Frontage Holdings Corporation $360M 36.5 3.1 3.0 4.6 9.8 7 LEAN BEAR 16.8
KNTPF Kintor Pharmaceutical Limited $120M -2.9 -116.6 -74.4 -145.6 2237.9 3 LEAN BEAR -10.2
HUMA Humacyte, Inc. $120M -0.9 -547.9 -500.7 -9064.5 -73.6 3 LEAN BEAR -72.0
LVCLF Algorae Pharmaceuticals Limited $20M -5.7 -47.4 -24288.6 — -100.0 3 LEAN BEAR 51.6
BCLI Brainstorm Cell Therapeutics Inc. $10M -0.8 119.2 76.7 — -100.0 1 LEAN BEAR 11.1
ENGNW enGene Holdings Inc. Warrants $10M -5.6 -2.3 134.1 — -100.0 2 LEAN BEAR -77.1
FORU ForU Holdings, Inc. — -0.0 759.2 -476.4 — -100.0 2 LEAN BEAR 100.0
CHNXF ChitogenX Inc. — -0.2 23.2 36.2 — — 2 LEAN BEAR 586.4
HLSQ Tessera Defense and Homeland Security Inc — — — — — — — LEAN BEAR —
JUNS Jupiter Neurosciences, Inc. — -0.1 -1888.7 5586.0 -9380.9 — 3 LEAN BEAR -98.0
CMND Clearmind Medicine Inc. — -0.1 -104.0 593.4 — — 2 LEAN BEAR -99.8
VINC Vincerx Pharma, Inc. — -0.0 -3136.4 910.2 — -18.7 5 LEAN BEAR -53.1
NURPF Neuren Pharmaceuticals Limited $1.8B 125.7 6.2 22.4 14.6 -68.5 5 LEAN BEAR 20.8
CUBT Curative Biotechnology, Inc. — -2.0 31.0 15.3 — — 4 LEAN BEAR -26.6
NRXP NRx Pharmaceuticals, Inc. $110M -3.6 131.2 61.3 -1500.5 — 5 LEAN BEAR -14.3
CNTN Canton Strategic Holdings Inc $150M -1.3 -14.6 -7.2 -1287.2 — 2 LEAN BEAR —
CNSP CNS Pharmaceuticals, Inc. $10M -0.2 -106.6 748.6 — — 3 LEAN BEAR -46.0
ADRX ADARx Pharmaceuticals, Inc. $1.9B — — — — — — LEAN BEAR —
ANNX Annexon, Inc. $610M -3.5 -105.3 -11323.3 — — 2 BEARISH 14.1
IMA ImageneBio Inc $50M -0.8 -40.7 -594.7 — — 3 BEARISH -49.7
GLUE Monte Rosa Therapeutics, Inc. $920M -5.0 -42.7 149.9 -483.9 -83.9 3 BEARISH -11.9
SANA Sana Biotechnology, Inc. $700M -3.5 -152.9 -242.3 — — 3 BEARISH -49.9
OCS Oculis Holding AG $490M -4.7 -44.0 -31.0 — -6.9 3 BEARISH -63.0
RLMD Relmada Therapeutics, Inc. $350M -3.6 -55.7 460.5 — — 3 BEARISH 43.8
IBO Impact BioMedical Inc. $30M -3.2 10.8 -30.4 -23300.0 — 5 BEARISH -45.8
LTRN Lantern Pharma Inc. $10M -0.5 -400.9 115.9 — — 2 BEARISH -80.9
KZIA Kazia Therapeutics Ltd ADR $10M -1.1 -104.5 62.7 — -99.2 4 BEARISH 14.1
ADAPY Adaptimmune Therapeutics plc $10M -0.1 -1341.1 268.4 -221.8 -54.0 0 BEARISH -47.7
ALLR Allarity Therapeutics, Inc. $10M -1.2 -157.1 -96.5 — — 2 BEARISH -30.8
PBMWW Psyence Biomedical Ltd. Warrant — — — — — — — BEARISH -63.9
LIPO Lipella Pharmaceuticals Inc. — -0.0 -361.8 4105.8 — -64.1 1 BEARISH -99.9
TRVN Trevena, Inc. — -0.0 344.3 -3198.4 -1745.2 -82.9 3 BEARISH -7.5
PKTX ProtoKinetix, Incorporated — -1.0 -117.2 -115.0 — — 2 BEARISH -94.6
IMMB Immunotech Laboratories, Inc. — — — — — — — BEARISH 100.0
ALLO Allogene Therapeutics, Inc. $430M -1.9 -42.4 -81.9 -919.8 — 5 BEARISH 5.7
PMVP PMV Pharmaceuticals, Inc. $70M -1.0 -70.9 815.8 — — 2 BEARISH -12.7
SPRO Spero Therapeutics, Inc. $60M 8.4 19.2 -128.5 — -7.0 7 BEARISH -48.9
SNANF Sona Nanotech Inc. $20M -13.1 526.4 252.2 — — 1 BEARISH -58.9
SNTI Senti Biosciences, Inc. $10M -0.1 -466.5 -430.9 -75000.0 — 2 BEARISH -90.4
IMUC EOM Pharmaceuticals Holdings, Inc. $10M -4.9 64.4 131.0 — — 4 BEARISH -42.8
HTDS Hard to Treat Diseases Inc. — — — — — — — BEARISH 0.0
AAPG Ascentage Pharma Group International $1.4B -6.3 -236.8 -144.8 -270.2 170.9 3 BEARISH -56.5
SNBIF SanBio Company Limited $1.3B -19.7 -55.8 -2935.2 — — 3 BEARISH 0.0
SLGL Sol-Gel Technologies Ltd. $230M -12.1 -35.9 -228.0 36.4 282.9 3 BEARISH 71.3
APLMW Apollomics, Inc. $170M -2.6 -233.7 845.7 1188.0 -75.9 3 BEARISH -64.6
MRKR Marker Therapeutics, Inc. $20M -2.1 -76.9 -1014.3 — -77.1 2 BEARISH -2.0
VRCI Verde Science, Inc. — -0.0 72.3 23.0 — — 5 BEARISH 100.0
NTII Neurobiological Technologies, Inc. — 0.0 48.7 441.6 89.7 99.7 4 BEARISH 0.0
IBOGF Universal Ibogaine Inc. — -0.5 -94.8 5.5 -9.4 208.2 4 BEARISH -98.6
RGIN Regenicin, Inc. — -0.0 16.9 4.1 — — 4 BEARISH 0.0
GLSHQ Gelesis Holdings, Inc. — -0.0 391.0 -233.6 -693.9 -45.8 3 BEARISH 0.0
HAVLF HAVN Life Sciences Inc. — -0.0 -275.3 -163.4 5734.1 876.8 3 BEARISH 0.0
TLOG TetraLogic Pharmaceuticals Corporation — -0.0 382.3 479.8 — — 1 BEARISH 0.0
PSYBF PsyBio Therapeutics Corp — -0.0 344.6 135.0 — — 2 BEARISH -90.0
MAJI Nextel Medical Corp. — 0.6 -2.6 42.9 — — 1 BEARISH —
GRI GRI Bio, Inc. — -0.0 -142.0 1227.5 — — 5 BEARISH -97.1
MRZM Marizyme, Inc. — -0.0 117.5 -190.1 — -69.0 3 BEARISH 0.0
BPMUF Basilea Pharmaceutica AG $960M 17.2 39.5 75.9 23.5 4.5 7 BEARISH 27.1
AKBA Akebia Therapeutics, Inc. $160M -7.1 -109.4 15.6 -18.1 7.5 6 BEARISH -75.9
ATRA Atara Biotherapeutics, Inc. $90M -7.3 46.3 30.3 -767.3 -96.7 2 BEARISH -44.5
SYGGF Synairgen plc — -0.2 -71.9 -381.4 — — 1 BEARISH -50.0
BTAX Biostax Corp. — -0.0 7.3 5.8 — — 2 BEARISH 100.0
CLYM Climb Bio, Inc. $590M -12.2 -27.1 -88.6 — — 2 BEARISH 381.9
MNPR Monopar Therapeutics Inc. $470M -31.4 -19.5 523.8 — — 2 BEARISH -9.7
ATGGF Actinogen Medical Limited $140M -8.8 -77.5 -235.8 — -100.0 1 BEARISH 17.2
BVAXF BioVaxys Technology Corp. — -0.9 310.6 48.4 — — 1 BEARISH -52.0
SQZB SQZ Biotechnologies Company — -0.0 -203.4 -410.2 — -44.6 0 BEARISH 4.3
VOGX Vogenx Inc. $260M — — — — — — BEARISH —
MEOBF Mesoblast Limited $2.0B -34.8 -9.9 -6.4 -23.4 613.8 5 BEARISH -21.4
MLYS Mineralys Therapeutics, Inc. $1.8B -5.0 -80.9 2274.6 — — 2 BEARISH -47.3
IMTX Immatics N.V. $1.1B -4.2 -47.8 -858.3 -683.4 -68.0 2 BEARISH -30.5
AKTS Aktis Oncology, Inc. $850M -16.0 -29.9 276.4 -713.5 -36.1 5 BEARISH 365552.2
ATTO Attovia Therapeutics, Inc. $630M -17.0 -294.4 -1137.2 -4597.1 -50.5 4 BEARISH 313.6
OLMA Olema Pharmaceuticals, Inc. $560M -3.5 -52.7 585.3 — — 2 BEARISH -14.8
BNTC Benitec Biopharma Inc. $300M -9.0 -33.2 1840.8 — — 3 BEARISH -34.9
TARA Protara Therapeutics, Inc. $140M -1.8 -45.8 -41.3 — — 2 BEARISH -51.4
OTLK Outlook Therapeutics, Inc. $130M -0.5 256.9 1372.0 -225766.7 -169.4 3 BEARISH -59.3
AKTX Akari Therapeutics, Plc $20M -0.0 -139.9 -175.8 — — 3 BEARISH -73.2
NCNA NuCana plc $10M -0.3 -70.7 -739.9 — — 4 BEARISH -74.8
LIFS Life Stem Genetics Inc. — -2.5 -126.7 -111.5 — — 2 BEARISH -50.0
RLFTY MindMaze Therapeutics Holding S.A. — -4.6 -36.8 -30.3 -1182.3 -95.8 2 BEARISH -95.4
LGVN Longeveron Inc. — -0.2 -203.6 -2062.6 -2116.0 -42.7 4 BEARISH -80.6
JAGX Jaguar Health, Inc. — -0.0 -501.9 -118.9 -1035.3 135.5 4 BEARISH -99.8
DRMA Dermata Therapeutics, Inc. — -0.2 -183.9 734.5 — — 2 BEARISH -78.5
ITMC Itoco Inc. — -0.0 303.4 96.7 — — 2 BEARISH 0.0
GBLX GB Sciences, Inc. — -0.0 19.5 17.2 -103.2 — 3 BEARISH -66.7
GNLX Genelux Corporation $90M -2.5 -168.9 20537.7 — — 2 BEARISH -69.7
ERNA Ernexa Therapeutics Inc. — -0.1 -320.7 626.9 — -100.0 5 BEARISH -93.3
AAGH America Great Health — 2.0 -12.2 22.4 -635.8 -5.1 4 BEARISH 33.3
MRES Institute of Biomedical Research Corp. — -2.3 301783.0 -6062.7 — — 1 BEARISH -81.2
CSPHF CStone Pharmaceuticals $1.4B -15.0 -51.4 -340.2 -123.0 135.6 5 BEARISH -15.4
DRTSW Alpha Tau Medical Ltd. $1.2B -12.8 -141.7 -17.1 — — 3 BEARISH 820.5
XCUR Exicure, Inc. $10M -0.8 -168.4 779.8 — — 2 BEARISH -78.2
PRVCF PreveCeutical Medical Inc. $10M -16.7 9.9 96.4 — — 3 BEARISH -49.5
LSTA Lisata Therapeutics, Inc. $10M -0.6 -99.9 590.1 — -90.7 2 BEARISH -62.1
ERNAW Ernexa Therapeutics Inc. Warrants — — — — — — — BEARISH —
PROT Proteonomix, Inc. — -0.0 77.5 -1239.4 — -63.1 4 BEARISH 0.0
NBIO Nascent Biotech, Inc. — -0.0 230.6 328.8 — — 5 BEARISH -77.8
RNUGF ReNeuron Group plc — -0.0 -106.8 210.1 -1809.6 -68.2 1 BEARISH 0.0
PFND Pathfinder Cell Therapy, Inc. — -0.0 22.4 46.3 — — 2 BEARISH 0.0
CDXI Cardax, Inc. — -0.0 81.1 38.5 -1740.8 -27.3 2 BEARISH 0.0
ADYX Adynxx, Inc. — -0.0 1148.3 259.7 — -95.1 2 BEARISH 0.0
PANC Panacos Pharmaceuticals, Inc. — -0.0 -168.8 -792.8 -33966.7 -45.9 1 BEARISH 0.0
SYVC Synovics Pharmaceuticals, Inc. — — — — — — — BEARISH 0.0
GHRS GH Research PLC $1.2B -20.7 -18.8 2015.5 — — 2 BEARISH 44.6
DSGN Design Therapeutics, Inc. $640M -9.4 -34.1 1787.8 — — 1 BEARISH 59.0
TENX Tenax Therapeutics, Inc. $50M -1.3 -59.8 1235.8 — — 1 BEARISH -74.9
HNSBF Hansa Biopharma AB (publ) $330M -4.9 159.8 1182.7 -541.7 -3.7 2 BEARISH -28.2
VICP Vicapsys Life Sciences, Inc. $10M -20.5 31.3 17.6 — — 5 BEARISH -73.3
ANTH Anthera Pharmaceuticals, Inc. — -0.0 -251.4 1107.5 — — 1 BEARISH 9900.0
PLYX Polaryx Therapeutics, Inc. Common Stock $90M -15.5 -35.9 437.3 — — 2 BEARISH —
CASIF CASI Pharmaceuticals, Inc. — — — — — — — BEARISH —
IDRSF Idorsia Ltd $1.4B -3.5 27.1 -344.5 -203.1 -8.1 1 BEARISH 19.6
VBIZF Viva Biotech Holdings $400M 13.9 4.5 4.2 8.0 2.9 7 BEARISH -35.1
SYRS Syros Pharmaceuticals, Inc. — -0.0 -777.0 960.6 — -90.5 0 BEARISH 0.0
FPMI FluoroPharma Medical, Inc. — -0.0 22.7 39.7 — — 2 BEARISH 100.0
CASBF CanSino Biologics Inc. $1.4B 399.2 0.8 -1.2 11.0 32.5 7 BEARISH -39.1
CRVS Corvus Pharmaceuticals, Inc. $890M -16.4 -35.4 -415.6 — — 4 BEARISH 33.8
NKTR Nektar Therapeutics $1.1B -5.8 -35.8 -29.2 -401.0 -27.2 3 BEARISH -38.4
RGNX REGENXBIO Inc. $440M -1.9 -137.6 -368.4 21.0 12.0 2 BEARISH -46.8
BLSM BlossomHill Therapeutics, Inc. $430M — — — — — — BEARISH —
TECX Tectonic Therapeutic, Inc. $390M -4.5 -33.8 -6371.3 — — 1 BEARISH 10.4
IPSC Century Therapeutics, Inc. $260M -1.4 -49.7 -60.0 — -100.0 2 BEARISH 150.0
NAGE Niagen Bioscience Inc $190M 13.1 21.8 44.7 3.2 11.0 6 BEARISH -66.6
MAIA MAIA Biotechnology, Inc. $70M -1.8 -218.7 330.4 — — 3 BEARISH -22.7
HMTXF Hemostemix Inc. $10M -2.4 69.9 190.1 — — 1 BEARISH -44.5
SCPS Scopus BioPharma Inc. — -0.0 132.3 53.6 — — 2 BEARISH 33.3
BITRF Biotron Limited — -3.6 -87.5 -87.8 -113.4 -71.0 0 BEARISH -90.7
THER Theralink Technologies, Inc. — -0.0 6.0 -69.7 5363.6 32.8 2 BEARISH 0.0
CVKD Cadrenal Therapeutics, Inc. Common Stock — -0.2 -275.2 -540.4 — — 3 BEARISH -92.5
MLECW Moolec Science S.A. — -0.0 -174.7 -31.5 -91.8 170.4 3 BEARISH -3.8
VIVS VivoSim Labs, Inc. — -0.0 -343.1 241.9 -7433.3 202.7 2 BEARISH -93.6
PPTDF PeptiDream Inc. $870M -39.6 -7.1 -9.6 -25.7 47.8 4 BEARISH -38.7
SPHRY Starpharma Holdings Limited $220M -26.9 -46.5 -441.4 -725.1 186.8 4 BEARISH 64.3
HRGN Harvard Apparatus Regenerative Technology Inc. $30M -4.9 239.0 256.6 -409.4 — 2 BEARISH —
LPCN Lipocine Inc. $10M -0.8 -60.9 662.3 -1379.6 -62.7 2 BEARISH -46.5
BRAXF Braxia Scientific Corp. — -0.1 -254.6 -2393.3 -184.2 27.6 3 BEARISH 0.0
SIGY Sigyn Therapeutics, Inc. — -0.0 61.7 32.8 — -100.0 1 BEARISH -99.0
VRPX Virpax Pharmaceuticals, Inc. — -0.0 2.6 0.4 — — 1 BEARISH -96.2
VRAX Virax Biolabs Group Limited — -0.0 -110.9 -481.7 -40439.1 121.6 4 BEARISH 105.4
ATXI Avenue Therapeutics, Inc. — -0.4 -120.0 178.4 — -100.0 2 BEARISH -47.1
SCNI Scinai Immunotherapeutics Ltd. — -0.0 -19.2 -53.3 -435.4 162.7 2 BEARISH -63.4
CALA Calithera Biosciences, Inc. — -0.0 -141.5 979.6 — -100.0 1 BEARISH -50.0
ANRO Alto Neuroscience, Inc. $860M -9.4 -49.2 -201.4 — — 3 BEARISH 90.5
ABUS Arbutus Biopharma Corp $830M 5.5 89.6 86.7 -507.2 1078.8 4 BEARISH -3.4
HOPHF Hemogenyx Pharmaceuticals Plc $20M -3.7 -628.5 -474.6 — — 4 BEARISH 0.0
NUVB Nuvation Bio Inc. $1.6B -10.6 -47.8 70.2 -198.3 1083.6 4 BEARISH -8.7
AUTL Autolus Therapeutics plc $410M -1.5 -132.9 451.5 -85.6 292.0 3 BEARISH -1.2
PLX Protalix BioTherapeutics, Inc. $210M 10.7 31.2 47.1 19.0 30.1 5 BEARISH 8.8
RLYB Rallybio Corporation $90M 3.5 34.5 -1198.7 — -35.6 6 BEARISH 2462.0
ALZN Alzamend Neuro Inc $10M -0.5 -163.2 401.5 — — 1 BEARISH -51.4
AFFY Affymax, Inc. — -0.0 98.1 -302.0 17164.3 -99.9 5 BEARISH -11.1
OCUL Ocular Therapeutix, Inc. $1.4B -5.1 -73.0 -31671.3 -584.5 -8.1 3 BEARISH -36.9
LRMR Larimar Therapeutics, Inc. $240M -1.3 -139.6 590.9 — — 2 BEARISH -41.5
LXEO Lexeo Therapeutics, Inc. Common Stock $230M -2.7 -46.8 -249.1 — — 3 BEARISH -68.2
MENS Jyong Biotech Ltd. Ordinary Shares $130M — — — — — — BEARISH -95.9
ADAG Adagene Inc. $90M -5.7 -28.6 111.8 -1011.1 8927.0 5 BEARISH 44.3
WINT Windtree Therapeutics, Inc. — -0.0 1111.0 -2375.5 — — 3 BEARISH -99.7
SILO Silo Pharma, Inc. — -0.3 -91.2 645.1 — -25.0 3 BEARISH 135.4
OMER Omeros Corporation $1.2B 9.4 -89.2 71.8 46.4 — 5 BEARISH 131.9
AVBP ArriVent BioPharma, Inc. $1.0B -4.3 -53.1 2345.1 — — 3 BEARISH -19.3
EPRX Eupraxia Pharmaceuticals Inc. $450M -7.2 -68.6 8742.2 — — 3 BEARISH 33.5
CABA Cabaletta Bio, Inc. $250M -1.0 -93.2 -1308.0 — — 3 BEARISH -45.5
ARMP Armata Pharmaceuticals, Inc. $140M -0.6 127.8 -54.7 2953.8 -35.1 2 BEARISH -37.6
VRXA Veraxa Biotech Holding AG $140M — — — — — — BEARISH —
UNCY Unicycive Therapeutics, Inc. $110M -2.2 -101.1 349.9 — — 4 BEARISH -28.2
INO Inovio Pharmaceuticals, Inc. $60M -0.8 -409.9 257.7 — -100.0 1 BEARISH -62.7
VERU Veru Inc. $40M -3.8 -62.3 -211.2 — -100.0 3 BEARISH -40.3
ANVS Annovis Bio, Inc. $40M -0.6 -703.7 170.2 — — 1 BEARISH -52.6
SEOVF Sernova Corp. $30M -3.7 57.0 76.3 — — 3 BEARISH -35.6
DVHGF Devonian Health Group, Inc. $20M — -76.1 -75.1 -1098.1 -91.5 1 BEARISH 37.7
DYAI Dyadic International, Inc. $20M -1.8 522.6 1288.0 -221.0 1.5 3 BEARISH -66.6
BIORQ Biora Therapeutics, Inc. — — — — — — — BEARISH —
ATRX Adhera Therapeutics Inc — -0.0 18.6 6.5 — — 1 BEARISH 0.0
SXTP 60 Degrees Pharmaceuticals, Inc. — -0.1 -321.8 -390.2 -1089.2 68.0 3 BEARISH -43.8
EVGN Evogene Ltd. — -0.4 265.3 101.3 -509.5 -80.4 3 BEARISH -70.5
BLEG Branded Legacy, Inc. — -0.0 2011.7 147.0 — -29.4 2 BEARISH -98.7
CRIS Curis, Inc. — -0.0 455.3 -23281.0 — -62.2 3 BEARISH -98.5
AMPE Ampio Pharmaceuticals, Inc. — -0.0 -114.0 1652.6 -838.4 — 4 BEARISH 5806.4
ORIC ORIC Pharmaceuticals, Inc. $1.4B -6.9 -39.8 -102.9 — — 3 BEARISH -30.6
KPRX Kiora Pharmaceuticals, Inc. $10M -0.9 -56.4 -2884.1 — — 2 BEARISH -6.7
BCTXZ BriaCell Therapeutics Corp. Warrant — -0.3 -168.1 -2016.9 — — 1 BEARISH -69.3
RAPP Rapport Therapeutics, Inc. Common Stock $1.2B -7.4 -40.0 3981.5 — — 4 BEARISH -15.0
DRTS Alpha Tau Medical Ltd $1.2B -12.8 -141.7 -17.1 — — 3 BEARISH 220.9
MGTX MeiraGTx Holdings plc $880M 12.8 72.3 96.7 50.0 948.3 7 BEARISH 9.9
ORMP Oramed Pharmaceuticals Inc. $170M 1.0 74.1 -4.3 — -100.0 4 BEARISH 75.5
BRIBF Brii Biosciences Limited $90M -3.5 -10.3 -62.6 — 22.5 4 BEARISH -46.0
ELOX Eloxx Pharmaceuticals, Inc. $40M -8.6 -107.5 81.5 — — 4 BEARISH 1311999900.0
SYBX Synlogic, Inc. $10M -19.6 -5.3 306.3 — — 2 BEARISH -40.7
FBIOP Fortress Biotech, Inc. $130M 0.6 107.5 -87.8 -2.5 15.5 6 BEARISH 118.1
ORGS Orgenesis Inc. — -0.0 764.3 1083.0 2628.2 -192.0 1 BEARISH -74.1
AVLN Avalyn Pharma Inc. Common Stock $1.1B — — — — — — BEARISH —
APMD Apnimed, Inc. $790M — — — — — — BEARISH —
CBIO Crescent Biopharma, Inc. $480M -1.8 -107.7 1928.6 — — 5 BEARISH 3.9
KYTX Kyverna Therapeutics, Inc. $330M -2.0 -87.2 14267.8 — — 2 BEARISH -24.6
MIST Milestone Pharmaceuticals Inc. $80M -1.1 -35522.6 587.8 -5118.8 — 5 BEARISH -62.3
RECEF Recce Pharmaceuticals Ltd $70M -6.3 151.4 200.5 — -100.0 2 BEARISH -56.0
TELO Telomir Pharmaceuticals, Inc. Common Stock $70M -0.7 -213.1 3515.1 — — 4 BEARISH -35.7
NMRA Neumora Therapeutics, Inc. Common Stock $70M -0.3 -187.1 231.9 — — 2 BEARISH -77.6
CNTB Connect Biopharma Holdings Limited $50M -1.0 -105.5 1034.1 -1249.0 49.8 2 BEARISH -47.2
CVM CEL-SCI Corporation $30M -0.6 -252.5 -142.9 — -100.0 4 BEARISH -82.3
ARTL Artelo Biosciences, Inc. $10M -0.0 -705.7 -1031.2 — — 5 BEARISH -92.2
FNAM Evolutionary Genomics, Inc. — -0.0 62.2 -99.6 — — 2 BEARISH 0.0
SYBE SYBLEU Inc — -3.1 71.5 -202.2 -685.7 — 2 BEARISH 0.0
RGRX RegeneRx Biopharmaceuticals, Inc. — -0.0 53.5 45.8 -2006.3 -0.0 3 BEARISH 450.0
BICTF Biocure Technology Inc. — -0.1 -889.9 60.0 — — 1 BEARISH 0.0
GERN Geron Corporation $720M -9.7 -29.2 -74.1 -29.0 24.4 2 BEARISH -24.3
ZVRA Zevra Therapeutics, Inc. $580M 10.7 34.8 -1356.4 22.1 119.4 6 BEARISH -7.0
PHAT Phathom Pharmaceuticals, Inc. $460M -4.9 26.4 8.9 -23.7 110.2 4 BEARISH -54.5
FTH Faeth Therapeutics, Inc. $440M — — — — — — BEARISH —
CLVLF Clinuvel Pharmaceuticals Limited $250M 10.7 13.2 126.7 41.1 -1.1 6 BEARISH -32.0
UPB Upstream Bio, Inc. $150M -1.0 -46.0 -1266.4 -5136.1 49.2 3 BEARISH -82.1
CUE Cue Biopharma, Inc. $140M -0.8 -1603.5 1241.9 -1943.2 354.4 3 BEARISH -8.4
LENZ LENZ Therapeutics, Inc. $100M -0.8 -59.2 17313.3 -581.8 329.5 3 BEARISH -89.7
ACRV Acrivon Therapeutics, Inc. Common Stock $70M -1.0 -64.6 5251.5 — — 1 BEARISH -14.3
NDTP NDT Pharmaceuticals Inc. $50M -29.4 -3.8 -1.5 -458.3 — 4 BEARISH -87.3
INNMF Amplia Therapeutics Limited $30M -5.1 -24.9 -86.9 — -100.0 2 BEARISH 10.2
RVXCF Resverlogix Corp. $20M -1.5 11.5 25.3 — — 4 BEARISH -30.1
DTCFF Defence Therapeutics Inc. $20M -3.1 -237.8 -86.8 — — 4 BEARISH -56.4
OTLC Oncotelic Therapeutics, Inc. $10M 0.0 181.4 -1.4 155.3 — 5 BEARISH -82.1
ICU SeaStar Medical Holding Corporation $10M -0.6 -356.9 415.0 -606.5 123.6 4 BEARISH -58.3
INTS Intensity Therapeutics, Inc. $10M -0.7 -195.9 4123.4 — — 5 BEARISH -44.7
PLRZ Polyrizon Ltd. $10M -1.9 -21.4 -68.2 — — 0 BEARISH 31.6
PHIO Phio Pharmaceuticals Corp. $10M -0.7 -113.7 2701.6 — — 2 BEARISH -57.6
CDT CDT Equity Inc. — -0.0 13.1 5.4 9.1 — 7 BEARISH -97.5
APUS Apimeds Pharmaceuticals US, Inc — -0.1 -100.1 -12.6 — — 2 BEARISH -84.5
ADTX Aditxt, Inc. — -0.0 622.6 49.4 -131159.8 -74.1 1 BEARISH -100.0
AMBS Amarantus BioScience Holdings, Inc. — -0.0 7.3 3.8 -4080.5 — 3 BEARISH -66.7
YECO EV Biologics, Inc. — -0.0 16.2 18.1 18.6 264.7 5 BEARISH -99.9
BRTX BioRestorative Therapies, Inc. — -0.1 -241.1 2112.9 -9298.3 -8.5 3 BEARISH -95.5
AFMDQ Affimed N.V. — — — — — — — BEARISH —
SPRC SciSparc Ltd. — -0.0 -519.9 -161.9 -1891.2 -26.8 5 BEARISH -78.1
MTNB Matinas BioPharma Holdings, Inc. — -0.1 -154.3 -504.1 — — 4 BEARISH -91.7
AGNPF Grey Matters Health Inc. — — -140.9 -64.7 — — 3 BEARISH -51.7
VBIO Valion Bio, Inc. — -0.0 -240.8 -48.0 — -281.4 2 BEARISH —
RGBPP Regen BioPharma, Inc. — -0.0 20.3 12.8 -1079.8 0.0 4 BEARISH -98.5
NVAX Novavax, Inc. $1.6B -6.8 323.7 29.2 -94.2 -61.6 2 BEARISH 18.6
PRQR ProQR Therapeutics N.V. $180M -3.2 -57.9 139.7 -99.6 12.7 2 BEARISH -50.7
AMGXF AnGes, Inc. $140M -3.0 -160.6 -111.8 -531.3 -16.1 4 BEARISH 0.0
BBIXF Bonus BioGroup Ltd. $50M -17.2 3245.0 2543.1 — — 2 BEARISH 13233.3
INTI Inhibitor Therapeutics, Inc. $10M -4.2 358.8 88.0 — — 1 BEARISH 59.8
MYMX Mymetics Corporation — -0.0 16.6 357.9 -3012.0 -62.8 2 BEARISH 0.0
NWPHF Newron Pharmaceuticals S.p.A. $410M -6.6 83.9 -32.1 -513.4 — 1 BEARISH —
VRXAW Veraxa Biotech AG — — — — — — — BEARISH —
SRNE Sorrento Therapeutics, Inc. — -0.0 1502.8 468.4 -633.7 16.9 2 BEARISH -98.3
SNDX Syndax Pharmaceuticals, Inc. $1.2B -5.7 -255.9 -270.9 -67.8 222.3 4 BEARISH 9.2
CTMX CytomX Therapeutics, Inc. $510M -5.2 -37.8 305.9 -1457.4 -87.0 2 BEARISH -29.8
ASMB Assembly Biosciences, Inc. $400M 37.4 -0.0 56.2 -28.8 125.1 4 BEARISH -31.0
MPLT MapLight Therapeutics, Inc. $340M -1.5 -57.5 -366.6 — — 2 BEARISH -56.5
CTNM Contineum Therapeutics, Inc. $270M -5.3 -28.0 -541.6 — — 4 BEARISH -18.4
ABEO Abeona Therapeutics Inc. $250M -4.0 -43.1 -5983.3 -177.4 6280.0 2 BEARISH -17.9
CRBU Caribou Biosciences, Inc. $60M -0.5 -78.3 -695.0 -1619.9 10.0 3 BEARISH -80.0
IBIO iBio, Inc. $50M -2.5 -65.7 21688.6 — -75.0 4 BEARISH -37.2
CLRB Cellectar Biosciences, Inc. $10M -0.3 -119.6 717.6 — — 3 BEARISH -65.5
AIM AIM ImmunoTech Inc. $10M -0.0 -2382.3 -513.5 -14569.2 -21.5 5 BEARISH -93.3
BTAIQ BioXcel Therapeutics, Inc. — — — — — — — BEARISH —
ASCLF Ascletis Pharma Inc. $770M -7.8 -28.4 -7144.0 — -60.6 2 BEARISH -40.0
ACHV Achieve Life Sciences, Inc. $670M -4.4 -845.0 24.6 — — 2 BEARISH 46.4
NVCT Nuvectis Pharma, Inc. $650M -14.0 -214.6 174.4 — — 1 BEARISH 180.3
IRD Opus Genetics, Inc. $290M -2.9 -4796.5 59.8 -1072.6 -36.1 3 BEARISH 84.0
PALI Palisade Bio, Inc. $230M -2.2 -51.4 815.6 -2114.8 — 5 BEARISH -28.3
GALT Galectin Therapeutics Inc. $210M -8.3 21.9 99.4 — — 2 BEARISH -30.6
MGNX MacroGenics, Inc. $140M -11.2 -32.6 33.8 59.4 2.3 2 BEARISH 29.3
SEER Seer, Inc. $110M -1.6 -26.4 -58.8 -544.8 -13.3 3 BEARISH -16.0
COYA Coya Therapeutics, Inc. $90M -3.8 -60.5 -18820.6 -2723.4 1793.8 4 BEARISH -37.2
MNOV MediciNova, Inc. $70M -6.8 -25.6 -78.2 -504.8 583.9 3 BEARISH 21.5
OSTX OS Therapies Incorporated $60M -1.1 1924.5 268.9 — — 1 BEARISH -35.2
HRTX Heron Therapeutics, Inc. $60M -1.7 334.6 -7.6 -14.6 1.0 3 BEARISH -73.8
XLO Xilio Therapeutics, Inc. $50M -5.4 -55.0 43.1 -34.1 327.3 6 BEARISH 864.5
GANX Gain Therapeutics, Inc. $50M -2.4 -268.3 1288.8 — — 4 BEARISH -38.5
ALPS Alps Group Inc $50M — — — — — — BEARISH —
MREO Mereo BioPharma Group plc $40M -1.6 -67.8 6194.3 — -100.0 2 BEARISH -85.2
DWTX Dogwood Therapeutics, Inc. $40M -0.1 -47.8 -39.7 — — 2 BEARISH -79.9
PVCT Provectus Biopharmaceuticals, Inc. $20M -3.9 78.1 83.4 — -100.0 5 BEARISH -37.8
COCP Cocrystal Pharma, Inc. $20M -1.2 -311.7 -3697.6 -3013.3 — 2 BEARISH -18.7
IMRN Immuron Limited $10M -2.5 -40.2 -187.8 -54.4 -29.7 5 BEARISH -59.1
PHYOF IXICO plc $10M -6.0 -15.8 -23.6 -28.5 13.2 2 BEARISH 0.0
PASG Passage Bio, Inc. $10M -0.3 -169.1 159.0 — — 3 BEARISH -53.2
GLWLF Glow Lifetech Corp. $10M -50.0 -11.1 -21.1 -26.6 59.2 5 BEARISH -16.1
EVLO Evelo Biosciences, Inc. — -0.0 948.0 605.0 — — 2 BEARISH -80.0
ISCO International Stem Cell Corporation — -2.7 30.4 -10.8 -2.7 3.4 6 BEARISH 16.0
HMGN Hemagen Diagnostics, Inc. — -0.0 29.1 -24.6 -18.6 -21.4 2 BEARISH 100.0
RCAR RenovaCare, Inc. — -0.0 -436.6 812.3 — — 2 BEARISH -99.0
ELAB PMGC Holdings Inc. — -0.0 -73.0 -66.6 -225.1 408.6 3 BEARISH -100.0
CHMMF Chimeric Therapeutics Limited — -0.0 655.2 80.8 — -100.0 2 BEARISH 0.0
LIANY LianMedical — 1.0 74.7 -612.1 — — 6 BEARISH -35.6
VCNX Vaccinex, Inc. — -0.4 776.6 414.6 -1584.0 226.6 3 BEARISH 4.2
AXIM AXIM Biotechnologies, Inc. — -1.6 3.0 24.9 -90.9 2142.6 5 BEARISH -62.7
LNAI Lunai Bioworks Inc. — -0.3 -21.6 30.2 — — 2 BEARISH -97.2
IMMX Immix Biopharma, Inc. $680M -9.2 -34.2 1509.2 — — 4 BEARISH 139.8
LXRX Lexicon Pharmaceuticals, Inc. $630M -9.9 -40.2 -99.7 -4591.8 -29.0 3 BEARISH 28.4
CADL Candel Therapeutics, Inc. $610M -6.1 -81.8 219.4 — — 2 BEARISH 60.6
MDXG MiMedx Group, Inc. $570M -30.4 2.9 5.8 -23.1 -2.4 6 BEARISH -41.3
AVIR Atea Pharmaceuticals, Inc. $320M -2.1 -58.1 974.6 — — 3 BEARISH 31.4
IKT Inhibikase Therapeutics, Inc. $220M -3.4 -52.0 920.5 — — 3 BEARISH 3.9
INMB INmune Bio, Inc. $40M -2.2 -74.8 -475.4 — -100.0 2 BEARISH -16.9
BMEA Biomea Fusion, Inc. $40M -1.3 -164.1 210.3 — — 2 BEARISH -54.4
CELU Celularity Inc. $30M -0.5 150.9 40592.8 13.0 -58.1 4 BEARISH -55.0
AVEFF Avecho Biotechnology Limited $20M -9.3 -268.2 103.4 -3227.5 -46.6 3 BEARISH 0.0
SER Serina Therapeutics, Inc. $20M -0.9 -206.3 1868.6 — -100.0 3 BEARISH -67.7
CMMB Chemomab Therapeutics Ltd. $10M -1.1 -82.7 -314.7 — — 1 BEARISH -63.9
CPMV Mosaic ImmunoEngineering Inc. — -2.8 9.2 7.5 — — 2 BEARISH -73.2
XRTX XORTX Therapeutics Inc. — -0.4 -99.1 -68.5 — — 3 BEARISH 63.0
OZYMF Strategic Partners A/S — 20.1 0.8 -117.5 1019.0 — 6 BEARISH 0.0
GNLKQ GeneLink, Inc. — -0.0 73.0 82.1 -183.0 -33.6 3 BEARISH 0.0
GLABF Gemina Laboratories Ltd. — -3.0 42.7 32.4 -7838.5 — 5 BEARISH -78.3
PBM Psyence Biomedical Ltd. — — — — — — — BEARISH 4.3
HXBM Helix BioMedix, Inc. — — — — — — — BEARISH -6.0
KRSA Korsana Biosciences, Inc. $150M — — — — — — BEARISH —
HBMHF HBM Holdings Limited $1.3B 12.7 24.1 53.0 53.0 54.6 4 BEARISH -38.1
GPCR Structure Therapeutics Inc. $1.2B -7.1 -20.2 -1134.3 — — 3 BEARISH -25.0
ARDX Ardelyx, Inc. $770M -13.7 -38.6 -22.7 -13.8 16.8 4 BEARISH -39.2
SLBT SL Science Holding Ltd $640M — — — — — — BEARISH —
PROK ProKidney Corp. $470M -2.7 9.2 13.2 -18948.0 55.2 1 BEARISH -52.8
ACIU AC Immune S.A. $250M -4.6 -78.5 96.7 12.4 -39.5 2 BEARISH -34.0
BOVNF BioInvent International AB (publ) $220M -2.7 -88.2 19958.5 -964.0 -87.2 1 BEARISH 0.0
BBOT BridgeBio Oncology Therapeutics Inc. $210M -0.0 -56.4 -157.3 — — 1 BEARISH -75.2
IVVD Invivyd, Inc. $180M -1.6 -95.9 -302.5 -310.8 26.3 2 BEARISH -71.3
SION Sionna Therapeutics, Inc. $160M -1.9 -32.3 -137.7 — — 0 BEARISH -89.5
CBUS Cibus, Inc. $110M -0.9 -225.9 -157.2 -2227.9 -10.3 2 BEARISH -14.6
VYGR Voyager Therapeutics, Inc. $110M -1.0 -54.1 -131.1 -773.2 -19.1 2 BEARISH -61.8
VXRT Vaxart, Inc. $100M 2.7 67.0 149.6 -49.6 201.1 6 BEARISH 13.3
ENGN enGene Holdings Inc. $100M -5.6 -2.3 134.1 — -100.0 2 BEARISH -80.2
TNYA Tenaya Therapeutics, Inc. $90M -0.8 -121.9 1769.3 -3909.3 — 3 BEARISH -75.7
HBPCF Helix BioPharma Corp. $60M -22.5 -50.8 -21.5 — — 3 BEARISH -55.5
PLRX Pliant Therapeutics, Inc. $50M -0.6 -50.3 -438.3 — — 3 BEARISH -50.6
KLRS Kalaris Therapeutics Inc $40M -1.0 -79.9 109.5 — — 0 BEARISH -58.6
ALGS Aligos Therapeutics, Inc. $30M -0.7 -113.6 -1246.4 -5.4 893.0 2 BEARISH -47.1
BYSI BeyondSpring Inc. $20M -3.2 20.3 15.7 — 100.0 2 BEARISH -70.7
NEUP Neuphoria Therapeutics Inc. $20M -0.5 -0.2 -0.2 -417.7 -91.9 4 BEARISH -25.8
PRRUF Immutep Limited $20M -0.5 -77.3 1092.5 -328.8 255.0 3 BEARISH -89.5
QNRX Quoin Pharmaceuticals, Ltd. $10M -0.3 -578.6 221.3 — — 1 BEARISH -68.9
MSLE Satellos Bioscience Inc. $10M — — — — — — BEARISH —
ANEB Anebulo Pharmaceuticals, Inc. $10M -1.8 -69.7 650.7 — — 1 BEARISH -89.8
TCRX TScan Therapeutics, Inc. $10M -0.2 -95.8 -159.4 -2888.6 2.2 2 BEARISH -91.3
FBLG FibroBiologics, Inc. Common Stock $10M -0.2 -660.1 -511.6 — — 4 BEARISH -88.8
CDIO Cardio Diagnostics Holdings, Inc. $10M -0.6 -75.4 -230.9 -28012.5 -25.9 3 BEARISH -56.5
APRE Aprea Therapeutics, Inc. $10M -0.5 -47.4 378.1 — -99.8 2 BEARISH -59.7
BCDA BioCardia, Inc. $10M -1.2 -1803.2 519.4 — — 3 BEARISH -27.5
HCWB HCW Biologics Inc. — -0.0 -133.5 -36.8 -3849.9 707.0 3 BEARISH -94.7
USRM U.S. Stem Cell, Inc. — -0.0 20.8 23.4 -2836.8 -59.1 5 BEARISH -99.0
ARNI Arno Therapeutics, Inc. — -0.0 250.7 111.6 — — 3 BEARISH 0.0
ENZC Enzolytics Inc. — -14.9 105.9 1.4 — — 7 BEARISH 0.0
EVFM Evofem Biosciences, Inc. — -0.1 20.1 26.0 -419.1 4.5 2 BEARISH -45.6
BBLG Bone Biologics Corporation — -0.2 -47.5 1744.6 — — 2 BEARISH -81.8
MBIO Mustang Bio, Inc. — -0.8 -58.1 36.6 — — 2 BEARISH -76.4
LIMN Liminatus Pharma, Inc. Class A Common Stock — -0.1 294.4 252.1 — — 4 BEARISH -95.4
BIOAF Bioasis Technologies Inc. — -0.1 135.1 538.8 -661.8 614.1 2 BEARISH -50.0
NCEL NewcelX Ltd. — 8.2 -48.0 -39.1 — — 2 BEARISH -79.0
SEPSF Asep Medical Holdings Inc — -0.3 -36.4 -75.5 -844.8 208.8 5 BEARISH -97.2
ENLV Enlivex Therapeutics Ltd. — 0.0 209.7 -0.4 — — 5 BEARISH -99.0
ENDV Endonovo Therapeutics, Inc. — -0.1 9.2 4.5 — -100.0 3 BEARISH -50.0
ARUXF Acrux Limited — -7.1 -48.5 -74.2 -26.5 289.9 7 BEARISH -90.0
MYNDF MYND Life Sciences Inc. — -2.2 9.5 34.0 — — 5 BEARISH -41.3
INBX Inhibrx Biosciences Inc. $1.4B -8.3 -1773.6 55.8 — -100.0 4 BEARISH 24.5
SKYE Skye Bioscience, Inc. $10M -0.1 -233.9 389.5 — — 3 BEARISH -3.1
PTIX Protagenic Therapeutics, Inc. — 0.2 -485.4 -367.8 — 100.0 6 BEARISH -78.7
EMMA Emmaus Life Sciences, Inc. — -0.4 9.9 -9.3 21.2 11.0 4 BEARISH 299.0
PHRRF PharmaTher Holdings Ltd. — -8.3 -76.9 234.4 — — 2 BEARISH -54.3
LIMNW Liminatus Pharma, Inc. Warrants — -0.1 -4165.9 252.1 — — 2 BEARISH -75.0
URGN UroGen Pharma Ltd. $1.7B -17.0 86.5 119.0 -19.8 169.5 2 BEARISH 61.9
MDCLF MedinCell S.A. $1.1B -29.2 472.2 81.6 -152.1 -14.8 3 BEARISH 333.5
ANL Adlai Nortye Ltd. $560M -5.2 -22.4 -317.5 -36.3 223.4 4 BEARISH 575.5
GNFTF Genfit S.A. $470M -5.6 -5084.0 -322.7 -124.0 27.5 3 BEARISH 153.5
ARTV Artiva Biotherapeutics, Inc. $300M -1.3 -36.6 -954.6 — — 3 BEARISH -15.1
TRGNF Transgene S.A. $120M -4.4 -64.1 -184.9 -5760.7 -185.8 4 BEARISH -53.1
PRNAF Alterity Therapeutics Limited $50M -2.3 -55.0 -401.1 — -100.0 2 BEARISH 8233.3
TVGN Tevogen Bio Holdings Inc. $30M -1.1 235.3 244.1 — — 5 BEARISH 860.5
BMNDF Biomind Labs Inc. $20M -13.3 85.8 101.7 — — 2 BEARISH 1483.5
RMTG Regenerative Medical Technology Group Inc. — -0.0 9.6 -3.3 -72.2 — 3 BEARISH —
GENSF Genus plc $1.8B 5.4 45.4 9.0 80.4 -3.8 5 BEARISH -19.4
AGMB AgomAb Therapeutics N.V. American Depositary Shares $450M — — — — — — BEARISH —
AVCTF Avacta Group Plc $420M -6.7 -2083.2 -753.6 -33970.3 -99.7 5 BEARISH -18.7
ALT Altimmune, Inc. $410M -2.7 -28.9 -43.1 — 55.0 4 BEARISH -47.0
AVTX Avalo Therapeutics, Inc. $370M -1.5 -36.3 -148.4 — -86.6 4 BEARISH -60.4
CAPR Capricor Therapeutics, Inc. $340M -2.5 -73.7 -107.5 — -100.0 3 BEARISH 0.8
SPHDF Santhera Pharmaceuticals Holding AG $280M -6.6 729.6 111.3 -44.5 106.3 7 BEARISH 49.1
ORYZF Oryzon Genomics S.A. $250M -79.9 -3.0 -7.2 -1.6 12.6 4 BEARISH -14.1
OCGN Ocugen, Inc. $250M -3.1 1211.7 190.2 -1671.8 -3.7 2 BEARISH -50.2
SCTX Scribe Therapeutics Inc. $250M — — — — — — BEARISH —
HLOSF Healios K.K. $240M 57.1 3.7 -129.2 17028.6 -47.1 4 BEARISH -48.6
IPHYF Innate Pharma S.A. $210M -2.5 267.9 125.3 -343.8 32.0 3 BEARISH -24.5
NBP NovaBridge Biosciences $160M -2.2 -45.7 -617.8 — — 1 BEARISH -73.2
ZNTL Zentalis Pharmaceuticals, Inc. $160M -0.8 -83.7 -2245.4 — -100.0 2 BEARISH 19.8
STRO Sutro Biopharma, Inc. $150M -0.5 266.8 43.6 -391.6 -56.3 4 BEARISH -19.9
NGEN NervGen Pharma Corp. Common stock $150M — — — — — — BEARISH —
CMPX Compass Therapeutics, Inc. $140M -1.8 -56.7 1526.3 — — 4 BEARISH -81.2
CDXS Codexis, Inc. $140M -3.8 -69.4 -37.8 -80.5 35.9 3 BEARISH -51.5
NKTX Nkarta, Inc. $130M -1.1 -38.8 -75.4 — — 1 BEARISH -18.1
AVXL Anavex Life Sciences Corp. $120M -5.0 -23.6 411.7 — — 2 BEARISH -84.7
VTVT vTv Therapeutics Inc. $100M -233.8 -11.7 91.2 — 216600.0 4 BEARISH 21.4
VANI Vivani Medical, Inc. $100M -3.3 -220.4 -127.1 — — 4 BEARISH -29.6
ORPOF OSE Immunotherapeutics S.A. $100M — — — — — — BEARISH —
TNXP Tonix Pharmaceuticals Holding Corp. $90M -0.4 -81.8 -276.2 -299.4 196.0 3 BEARISH -73.6
CNXU Conexeu Sciences Inc. $90M — — — — — — BEARISH —
JWCTF JW (Cayman) Therapeutics Co. Ltd $80M -2.4 -49.0 -68.1 -45.3 60.7 3 BEARISH -55.3
CRBP Corbus Pharmaceuticals Holdings, Inc. $80M -0.7 -95.6 738.2 — — 1 BEARISH -75.0
CRDF Cardiff Oncology, Inc. $70M -1.5 -94.1 443.4 -8876.9 -7.0 3 BEARISH -60.8
PTHS Pelthos Therapeutics Inc. $70M -0.4 4767.3 -97.0 -150.1 — 2 BEARISH -49.1
CGTX Cognition Therapeutics, Inc. $70M -3.9 -83.8 6061.8 — — 3 BEARISH -55.4
XBIT XBiotech Inc. $60M -1.3 -29.9 -201.2 — — 2 BEARISH -22.6
TLSA Tiziana Life Sciences Ltd $60M -4.6 -780.6 375.0 — — 1 BEARISH -49.7
VTIAF FamiCord AG $50M -6.4 -84.3 -13.6 -5.1 0.1 5 BEARISH -55.7
HYFT MindWalk Holdings Corp. $50M -4.5 -123.5 -481.3 -158.7 -15.9 4 BEARISH -31.8
EXOZ eXoZymes, Inc. $40M -3.5 -187.2 913.0 — — 2 BEARISH -65.9
ACET Adicet Bio, Inc. $40M -0.3 -78.1 -553.5 — — 4 BEARISH -73.6
RANI Rani Therapeutics Holdings, Inc. $40M -2.3 -179.1 245.5 -432.7 306.4 5 BEARISH -65.4
ALDX Aldeyra The $40M -1.8 -49.5 269.3 — — 4 BEARISH -86.9
IXHL Incannex Healthcare Limited $30M -2.4 -31.9 5284.2 — -100.0 4 BEARISH -74.2
AARD Aardvark Therapeutics, Inc. Common Stock $30M -0.5 -66.0 -3642.4 — — 1 BEARISH -87.1
BCTX BriaCell Therapeutics Corp. $30M -0.3 -179.9 -2435.2 — — 2 BEARISH -73.9
FLNA Filana Therapeutics, Inc. $30M -0.7 -13.5 38.9 — — 2 BEARISH —
MGX Metagenomi, Inc. Common Stock $30M -0.3 -60.6 -268.2 10693.4 -59.8 1 BEARISH -70.0
KYNB Kyntra Bio, Inc. $20M 0.1 -115.2 29.6 -812.3 — 2 BEARISH —
MVMDF More Life Company Corp. $20M -5.2 -167.0 -602.2 -5006.5 43.0 4 BEARISH 115.8
TELIF Telescope Innovations Corp. $20M 5.5 -229.2 -80.7 -116.8 66.3 2 BEARISH -19.4
MCRB Seres Therapeutics, Inc. $20M -0.8 -66.6 -87.8 622.4 — 3 BEARISH -89.6
ATYR aTyr Pharma, Inc. $20M -0.2 -98.4 -1890.1 — — 2 BEARISH -86.8
TRAW Traws Pharma, Inc. $10M -0.7 -711.4 133.9 — -100.0 1 BEARISH -86.2
TOVX Theriva Biologics, Inc. $10M -0.3 -101.9 -213.5 — — 2 BEARISH -42.0
PTN Palatin Technologies, Inc. $10M -1.0 -877.5 1176.9 -1449.1 — 5 BEARISH -12.7
GUTS Fractyl Health, Inc. $10M -0.1 1063.0 -568.7 — -100.0 5 BEARISH -94.3
VTGN VistaGen Therapeutics, Inc. $10M -0.1 -166.5 851.1 -882.8 287.3 4 BEARISH -95.6
OPTBF OptiBiotix Health Plc $10M -1.4 -102.1 -102.1 -231.5 -12.9 4 BEARISH 109900.0
TPST Tempest Therapeutics, Inc. $10M -0.1 -931.1 -564.2 — — 1 BEARISH -95.1
INAB IN8bio, Inc. $10M -0.5 -111.1 -576.1 — — 4 BEARISH -53.3
QNTM Quantum BioPharma Ltd. $10M -0.4 -425.3 175.1 — — 4 BEARISH -82.3
IMNN Imunon, Inc. $10M -0.2 -429.7 -226.7 — — 2 BEARISH -82.4
GTBP GT Biopharma, Inc. $10M -0.1 -798.9 927.8 — — 2 BEARISH -68.3
TVRD Tvardi Therapeutics, Inc. $10M -0.3 -126.2 296.9 — — 1 BEARISH -81.8
PXXLF Poxel S.A. $10M -0.4 34.8 129.6 -624.6 41.5 4 BEARISH -12.0
DARE Dare Bioscience, Inc. $10M -0.9 165.3 136.8 -1590.4 7816.7 3 BEARISH -66.5
HIND Vyome Holdings, Inc. $10M -0.1 -193.1 516.3 -2543.3 -98.0 4 BEARISH -68.8
GSGTF GenSight Biologics S.A. $10M -1.0 46.5 47.3 1190.6 -401.7 3 BEARISH -57.9
OGEN Oragenics, Inc. — -0.1 -1307.1 4273.7 — — 3 BEARISH -71.9
GSTC GlobeStar Therapeutics Corporation — -0.0 60.9 49.1 — — 4 BEARISH -99.0
SUVZ Suvanza Pharma, LLC — — — — — — — BEARISH 0.0
LABT Lakewood-Amedex Biotherapeutics, Inc. — — — — — — — BEARISH —
RADX Radiopharm Theranostics Limited — — — — — — — BEARISH -82.0
MBAI MBody AI Ltd. — — — — — — — BEARISH —
EFTR eFFECTOR Therapeutics, Inc. — -0.0 1737.6 607.9 — -91.9 4 BEARISH 0.0
DCOY Decoy Therapeutics Inc. — — — — — — — BEARISH —
RASP Actavia Life Sciences, Inc. — -0.1 20.1 14.5 — — 2 BEARISH -87.5
CLDI Calidi Biotherapeutics, Inc. — -0.0 -713.6 -1404.6 — — 4 BEARISH -97.2
GNPX Genprex, Inc. — -0.0 -203.9 3484.8 — — 4 BEARISH -99.0
KALA KALA BIO, Inc. — -0.0 -345.3 -913.5 — -100.0 4 BEARISH -99.5
TSOI Therapeutic Solutions International, Inc. — -0.1 -187.6 -130.3 -5123.0 -99.7 4 BEARISH 0.0
WSNAF Wesana Health Holdings Inc. — -0.1 1113.6 90.8 — — 3 BEARISH -80.1
CEROW CERo Therapeutics Holdings, Inc. — -0.0 101.5 60.5 — -100.0 1 BEARISH -84.2
NBRVF Nabriva Therapeutics plc — — — — — — — BEARISH -0.0
BNIGF Beroni Group Limited — -0.1 -1153.4 -274.8 -15945.7 40.9 5 BEARISH 0.0
SLXN Silexion Therapeutics Ltd. — -0.0 -17022.0 -931.4 — — 3 BEARISH -95.6
ZVSA ZyVersa Therapeutics, Inc. — -0.0 817.1 242.0 — -100.0 1 BEARISH -99.3
NIKI Niki BioSolutions, Inc. — — — — — — — BEARISH —
BIXT Bioxytran, Inc. — -0.7 92.2 68.7 — — 4 BEARISH -54.0
GOVX GeoVax Labs, Inc. — -0.0 -891.6 1530.7 — -100.0 3 BEARISH -98.6
TNGNQ Tengion, Inc. — — — — — — — BEARISH 0.0
XENO Xeno Transplants Corporation — -0.0 -286.5 78.1 — — 1 BEARISH 0.0
ZHCLF Zenith Capital Corp. — -0.2 35107.2 37766.2 -360.0 — 3 BEARISH 3233.3
MDCX Medicus Pharma Ltd. Common Stock — -0.0 -3904.0 -693.1 — — 3 BEARISH -97.9
VPRO Viropro Inc. — -0.0 -19.7 -4.8 -269.7 155.0 2 BEARISH 0.0
PHMMF Pharma Mar, S.A. $1.6B 21.0 24.9 35.9 -2.0 15.5 7 BEARISH -16.4
BCAX Bicara Therapeutics Inc. Common Stock $1.1B -3.1 -41.0 583.9 — — 2 BEARISH -42.6
IVEVF Inventiva S.A. $750M -6.2 -988.4 -371.6 -347346.6 -99.7 3 BEARISH -22.8
INRLF Valneva SE $640M -2.8 -118.0 -54.8 -89.3 -27.2 1 BEARISH -44.9
SPRY ARS Pharmaceuticals, Inc. $400M -1.7 -210.3 -424.3 -185.2 4.1 2 BEARISH -61.8
EIKN Eikon Therapeutics, Inc. Common Stock $390M — — — — — — BEARISH —
DMTRF 3-D Matrix, Ltd. $310M 12.4 75.0 31.1 9.4 57.0 6 BEARISH 61.3
NERV Minerva Neurosciences, Inc. $110M -0.1 337.5 10.0 — — 1 BEARISH -51.2
VRCA Verrica Pharmaceuticals Inc. $60M -2.0 473.3 437.4 -224.4 106.2 5 BEARISH -7.5
ONCY Oncolytics Biotech Inc. $50M -1.8 90135.4 285.1 — — 1 BEARISH -63.5
EDSA Edesa Biotech, Inc. $30M -1.5 -122.9 759.6 — — 1 BEARISH -2.7
EYPT EyePoint Pharmaceuticals, Inc. $30M -0.1 -148.7 -3014.8 -18633.1 -94.6 2 BEARISH -96.9
NRXBF NurExone Biologic Inc. $30M — — — — — — BEARISH —
IGC IGC Pharma, Inc. $30M -2.9 -129.2 -127.6 -1107.9 -15.4 1 BEARISH -43.1
CRVO CervoMed Inc. $30M -0.7 -107.6 1244.8 — — 2 BEARISH -68.5
BSEM BioStem Technologies, Inc. $30M -0.9 -74.7 -84.3 -113.6 -119.6 2 BEARISH -67.9
CNTX Context Therapeutics Inc. $20M -0.4 -76.1 841.7 — — 2 BEARISH -82.8
BXPHF Botanix Pharmaceuticals Limited $20M -0.3 -96.3 -131.6 -203.1 495.6 4 BEARISH -92.5
ACXP Acurx Pharmaceuticals, Inc. $10M -0.3 -128.1 241.9 — — 3 BEARISH -83.8
RDTCF Rapid Dose Therapeutics Corp. $10M -4.2 49.3 80.2 -86.2 4.3 4 BEARISH -58.4
BLRX BioLineRx Ltd. $10M -1.1 -63.5 -113.0 -1029.3 -94.3 3 BEARISH -46.8
ACTU Actuate Therapeutics Inc $10M -0.4 2457.6 541.3 — — 3 BEARISH -94.7
AIMD Ainos, Inc. $10M -0.3 -196.3 -69.4 -3022849.3 -87.7 1 BEARISH -77.2
KTTA Pasithea Therapeutics Corp. $10M -0.2 -65.5 -453.2 — — 4 BEARISH -45.8
RVPH Reviva Pharmaceuticals Holdings, Inc. $10M -0.1 -32.2 45.6 — — 4 BEARISH -29.9
MTVA MetaVia Inc. $10M -0.3 -175.7 209.3 — — 0 BEARISH -89.3
CODX Co-Diagnostics, Inc. — -0.0 -174.8 -218.8 -3782.4 -28.1 3 BEARISH -98.8
NAVBQ Navidea Biopharmaceuticals, Inc. — — — — — — — BEARISH —
HLUN HEALTHeUNIVERSE, Inc. — — — — — — — BEARISH -90.0
FAMDF Futura Medical plc — -0.3 -145.8 -370.5 -72.8 -70.7 2 BEARISH -86.7
KAPA Kairos Pharma, Ltd. — -0.3 -114.0 -301.0 — — 3 BEARISH -93.5
APVO Aptevo Therapeutics Inc. — -0.0 -420.3 -4688.7 — — 1 BEARISH -95.2
NSHSF NanoSphere Health Sciences Inc. — 9.5 4.6 11.1 — — 0 BEARISH 0.0
CANF Can-Fite BioPharma Ltd. — -0.2 -184.2 353.7 -2277.7 -40.1 2 BEARISH -82.5
PPBT Purple Biotech Ltd. — -0.0 -111.3 -99.1 — — 2 BEARISH 60.8
BXRXQ Baudax Bio, Inc. — — — — — — — BEARISH -90.0
NRSN NeuroSense Therapeutics Ltd. — -0.3 779.3 571.3 — — 3 BEARISH -89.7
NMLSF Restart Life Sciences Corp. — -1.7 -214.3 -153.9 -307.0 — 2 BEARISH -63.3
ZLDAF Zelira Therapeutics Limited — -1.6 80.8 147.8 -185107971.7 -99.3 1 BEARISH -7.8
PMCB PharmaCyte Biotech, Inc. — -0.1 -44.0 793.8 — — 2 BEARISH -66.1
OXBOF Oxford BioDynamics Plc — -0.3 -214.9 -155.8 -649.8 33.6 3 BEARISH -81.1
CELZ Creative Medical Technology Holdings, Inc. — -0.4 -78.0 8335.2 — -50.0 2 BEARISH -86.0
XSNX NovAccess Global Inc. — -0.0 27.7 18.0 — — 3 BEARISH 0.0

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

VNDA vs Benchmarks

ROIC
VNDA
-201.0
Industry
10.0
Gross Margin
VNDA
93.0
Industry
84.2
Op Margin
VNDA
-126.3
Industry
-207.9
Net Margin
VNDA
-123.7
Industry
-206.2
Sector
-157.4
Revenue Growth
VNDA
6.0
Sector
0.8
P/E Ratio
VNDA
-0.9
Sector
17.0
ROE
VNDA
-77.8
Sector
-70.3
Piotroski F
VNDA
3.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms